Pas de Deux: Environment & Microbial Communities - Interactions, Influence, & Analysis by Reichenberger, Erin Renée
Pas de Deux: Environment & Microbial Communities –
Interactions, Influence, & Analysis
A Thesis
Submitted to the Faculty
of
Drexel University
by
Erin Renée Reichenberger
in partial fulfillment of the
requirements for the degree
of
Doctorate of Philosophy in School of Biomedical Engineering, Science, &
Health Systems
April 2015
c© Copyright 2015
Erin Renée Reichenberger. All Rights Reserved.
This work is licensed under the terms of the Creative Commons Attribution-
ShareAlike license Version 3.0. The license is available at
http://creativecommons.org/licenses/by-sa/3.0/
ii
Dedications
To a lost, little, afro-headed 5-year old. . .
Dedications ii
iii
Acknowledgements
Thank you to all of my committee members for agreeing to take this ride with
me. Many thanks to Uri Hershberg for being my confidant, supporter, collaborator,
sparing partner, and friend. A special note of appreciation to Gail Rosen for starting
me down the Ph.D. path, for supporting me in that first year when no one else
would, and for pushing me to apply for fellowships. Accolades to Ruti for sharing
with me how to think, write, and speak about science (as well as for churning out
ideas like I have never seen before). Nods to my mates in both the EESI and Systems
Immunolgy labs. Special nods to Steve Essinger and Yemin Lan for being excellent
lab mates. Big ups to Calvin Morrisson for being my rubber ducky and for teaching
me so much about programming. A very special nod to Greg – for the walks down
Market street, helping me debug all matter of things, for listening, understanding, and
on those rare occassions...for Rick-rolling me (you have walked through a door sir).
Many thanks to my friends Leigh & Dave for feeding me, for helping me prepare for
presentations, and for getting me out of the house when inertia dictated otherwise.
Aaron Rosenfeld...I am so glad we randomly sat next to each other in 2010 – you
have always been available for questions (even when we were separated by a very
large pond) and a pint – to say it succinctly, you are explicative awesome! I tip my
helmet to Jens who inspired me to continue on in the moments were the fatigue was
overwhelming. Thank you Tammy White for proofing this manuscript, for being a
good friend, for remembering the Linderman’s Framboise, and for always listening to
me without ever making me feel judged. Thank you to Natalia Broz, Danielle Crocker,
Acknowledgements iii
iv
and Lisa Williams who stopped what they were doing to help me so many times that
I cannot count that high. To Kathy Bryant, Ginger Kirby, Jaimie Dougherty, Taz
Kwok, and Dr. Lim for always being supportive. An endless supply of appreciation for
Chris O’Brien, Barbara Kneebone, Pam Tyler, Amer Thompson, Christophe Jackson,
Victor Ray, Chris Roy, Liz Figueroa, (the amazing) Koritha Mitchell, and many others
at the Ford Foundation who have been massively supportive and inspirational over
the last three years. To Rami and Miri Seliktar...for believing in me – even when I
had serious doubts. Thank you to all of my friends who choose to share their lives
with me, for supporting me, and for challenging me to be better; my life would be
so much less without you. So much love, appreciation, and awe goes out To Myke
Minbiole – you have been the most influential person in my life. And to two of my
closest friends Hap Brusca and Matt Stilger...thank you for being there during the
worst of everything. . . .
vTable of Contents
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
ABSTRACT .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Thesis Contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.2 Organization of the Thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
2. Evolutionary Theory, Microbes, Metagenomics, & Sequencing . . 4
2.1 Evolutionary Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.1.1 Codons, Mutations, & Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.1.2 Lateral Gene Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 An Introduction to Microbes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.2.1 The Importance of Microbes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.3 Microbiome & Experiments in Metagenomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.3.1 Sequencing Methods: 16S Sequences & Whole Shotgun Sequences 9
2.3.2 Analyzing NGS Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3. Complex Regional Pain Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
3.2.1 The Importance of Gastrointestinal Bacteria . . . . . . . . . . . . . . . . . . . . . . 15
3.2.2 Maladies & Microbial Communities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
3.2.3 Immunology & Microbial Communities . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
3.2.4 CRPS & the Gut-Brain Axis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.2.5 Targeting Bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.3.1 Subject Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
3.4 Sample Collection and Transport, DNA Extraction and Sequencing . . . . 20
3.4.1 Sequence Processing Pipeline and Microbial Analysis . . . . . . . . . . . . 20
3.4.2 Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.5 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.5.1 Subject Demographics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.5.2 Sequence Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.5.3 Sample Diversity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.5.4 Compositional Classification and Comparison. . . . . . . . . . . . . . . . . . . . . 26
3.5.5 Bacterial Community Structure Comparisons . . . . . . . . . . . . . . . . . . . . . 28
3.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
4. Prokaryotes & GC-content . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4.2 Another Explanation for Variation in Prokaryotic GC-Content . . . . . . . . . . 34
4.3 Material and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4.3.1 Data sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
vi
4.3.2 Assessing Genus Level Similarity between Environments . . . . . . . . . 36
4.3.3 Annotation of protein-coding genes and extraction of fourfold
degenerate 3rd codon positions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
4.3.4 Analysis Pipeline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.4.1 Mean GC-content and degree of variation in GC-content vary
greatly between prokaryotic phyla . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.4.2 GC-content varies across environments in a manner that cannot
be explained by differences in phylogeny. . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.4.3 GC-content of fourfold degenerate amino acids . . . . . . . . . . . . . . . . . . . 65
4.4.4 Different environments do not differ by the genera they contain. 68
4.4.5 Human gut samples that are dominated by Actinobacteria tend
to be more GC-rich than other human gut samples. . . . . . . . . . . . . . . 71
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5. Investigating Environmental Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.2 The Dance-off: Prokaryotes and Phages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
5.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.3.1 Data sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.3.2 Assessing Environmental Influence Using Sample Metadata . . . . . 86
5.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.4.1 GC-content of Samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
5.4.2 Environmental Factors: Correlating GC-content and Metadata . 97
5.4.3 Bacteriophages and GC-content . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
5.4.4 Relationship between viral and prokaryotic samples from ma-
rine environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
5.5.1 Human Gut Environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
5.5.2 Merlot Vineyard Soil Environment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
5.5.3 "Water" Environment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
6. Contributions of this Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
6.1 Broader Impacts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
6.1.1 Complex Regional Pain Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
6.1.2 GC-Content . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
6.2 Recommendations for Future Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
6.2.1 Complex Regional Pain Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
6.2.2 GC-Content . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
BIBLIOGRAPHY .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
vii
List of Tables
2.1 NGS Pricing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3.1 MANOVA & ANOVA on PCoA axes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
3.2 Characteristics of study participants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.3 Calculated characteristics of study participants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.4 RDP LibCompare & t-test values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
4.1 Environmental sample demographics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.2 Spearman correlation coefficients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.3 IQR Spearman correlation coefficients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.4 Annotated Spearman correlation coefficients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.5 Spearman correlation coefficients summary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.6 Nucleotide count by AA position . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.7 Jaccard Similaity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.8 Hypergeometric Probability & Mann-Whitney-Wilcoxon results. . . . . . . . . . . . . 74
5.1 Prokaryotic Environmental sample demographics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
5.2 Viral Environmental sample demographics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
5.3 Merlot Spearman correlation coefficients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
5.4 "Water" Spearman correlation coefficients.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
5.5 Human Gut factor correlations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
5.6 Merlot factor correlations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
5.7 Metadata values for marine samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
viii
5.8 Spearman coefficients: "water" samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
5.9 CRISPRs from Merlot Soil Samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
5.10 Mann–Whitney U test for marine samples. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5.11 Spearman Correlations: Phyla mean GC vs viral mean GC.. . . . . . . . . . . . . . . . . 109
ix
List of Figures
2.1 How DNA becomes a protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.2 Codon Construction Wheel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.3 16S rRNA Analysis Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.4 Example of 16S rRNA Analysis Output . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
3.1 Rarefaction curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.2 Bacterial Relative abundance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.3 Principal coordinates analysis (PCoA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
4.1 Analysis Pipeline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.2 Relative Abundance: All Environments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.3 GC-levels for each phylum across all environments.. . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.4 Referential GC-Levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.5 Amino Acid Identity (AAI) values. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.6 Average GC-composition by environment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
4.7 Spearman Correlation Coefficients: All Environments . . . . . . . . . . . . . . . . . . . . . . . . 51
4.8 Spearman Correlation Coefficients: Human Gut Environments . . . . . . . . . . . . . . 52
4.9 Spearman Correlation Coefficients: Non-Human Environments. . . . . . . . . . . . . . 53
4.10 IQR Spearman Correlation Coefficients: All Environments . . . . . . . . . . . . . . . . . . 56
4.11 IQR Spearman Correlation Coefficients: Human Gut Environment . . . . . . . . . 57
4.12 IQR Spearman Correlation Coefficients: Non-Human Environments . . . . . . . . 58
4.13 Annotated Spearman Correlation Coefficients: All Environments . . . . . . . . . . . 61
x4.14 Annotated Spearman Correlation Coefficients: Human gut Environment . . . 62
4.15 Annotated Spearman Correlation Coefficients: Non-human Environments . 63
4.16 Annotated GC-levels by position . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.17 Mean GC of human gut samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4.18 Relative Abundance: Human Gut . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
5.1 H-NS Function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
5.2 CRISPR loci . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
5.3 Phylogenetic tree comprised of species from the phyla used in our analysis.
Color (inner circle) legend: Pink = Eukaryotes, Green = Archaea, Light
Violet = Bacteria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
5.4 Mean GC of Merlot vineyard soil samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
5.5 Merlot GC-levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
5.6 Prokaryotic Mean GC of "water" environmental samples . . . . . . . . . . . . . . . . . . . . . 93
5.7 GC-levels of "Water" environmental samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
5.8 Viral Mean GC of "water" environmental samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
5.9 Human Gut: GC-content vs. Age . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
5.10 Merlot mean GC colored by factors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
5.11 Mean GC-content: Prokaryotic "water" samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.12 Mean GC-content: Viral "water" samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
5.13 Mean GC-content: Prokaryotic and paired viral "water" samples . . . . . . . . . . . . 106
5.14 Delta-GC: Prokaryotes vs. Virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
xi
Abstract
Pas de Deux: Environment & Microbial Communities – Interactions, Influence, &
Analysis
Erin Renée Reichenberger Uri Hershberg, Ph.D (Advisor)
Microbes are everywhere and yet remain mostly invisible to our understanding of
how nature and the environment interact. Here, I present a set of studies which show
how environment influences the makeup of microbial populations (or microbiome),
and how they in turn influence their environment. I focus on two separate systems
and questions – the first being – can I find an impact of the microbiome in a physio-
logical disease unrelated to inflammatory bowel diseases (IBDs). To accomplish this,
I characterized the microbiome of the human gastrointestinal (GI) tract from multiple
people with Complex Regional Pain Syndrome (CRPS) and showed that it differs sig-
nificantly from the microbiome found in healthy individuals. I next widened my scope
and tried to identify how environment and history influenced the basic nucleotide ar-
chitecture of microbes. This is important as such factors are the underpinnings of
what is possible in the evolution of amino acid and proteins. I characterized the
nucleotide composition of the ten major phyla found across 14 different environments
(in each of which there were between 1 and 111 samples). I found that nucleotide
composition correlated across phylum by environment and by sample. This implies
that both phylogeny and environment influence nucleotide composition beyond the
selection of specific function. This is related to a current project where I describe what
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environmental determinants could influence microbial nucleotide composition. Some
preliminary results indicate that it may be a nucleotide arms race with the microbial
infecting phages. For the present, my research has shown that in studying the evo-
lution of microbes (and living systems in general) the influence of the environment
is much more deep-seated than previously considered. This has implications both
for bioinformatic methodological applications, but more importantly for our general
understanding of how and at what (time) scale selection works in evolution.

11. Introduction
1.1 Introduction
1.1.1 Thesis Contributions
In order to perform a large-scale study of microbial communities and interpret
the results, it is necessary to incorporate numerous tools from an equal number of
fields. The Central Dogma of Biology and biochemistry are required to understand
how DNA is expressed and for developing next generation sequencing (NGS) methods.
Statistics – specifically those employed in the ecological realm are necessary to analyze
the results. Because of the amount of data involved in metagenomic studies, one
must be well-versed in computer programming and scripting. Understanding human
physiology is necessary to understand why humans are influenced by more than their
own genetic material. Immunology comes into play not only in a human’s response
to microbes, but also in the innate and adaptive immunological techniques employed
by microbes in order to deflect infection by other microbes.
The main contributions of this work are as follows:
1. The publication resulting from the Complex Regional Pain Syndrome (CRPS)
research was the first to link the malady to the microbial community – offering
additional information to its cause as well as the possibility of new treatment
approaches [104].
2. The publication resulting from the research on prokaryotic nucleotide composi-
tion shows that the environment and phylogeny influence which nucleotides are
selected – which can – in some instances override a known AT-mutation bias
[105].
3. Finally, continuing with my work discussed in item two, I look at what envi-
Thesis Contributions 1
2ronmental factors could influence GC-content and advance the idea that one of
the influential factors on nucleotide composition may be the presence of bacte-
riophages.
1.1.2 Organization of the Thesis
The following chapters proceed as follows:
• Chapter Two focuses on much of the background required to understand evolu-
tion, microbes, metagenomics, and sequencing methods. As I study microbial com-
munities, this chapter contains a brief summary on microbes and their importance.
Lastly, in order to analyze the microbial community of an environment, I include a
discussion on what metagenomic studies entail and how investigators sequence ge-
nomic material found in metagenomic samples. This is meant to provide a cursory
understanding for the concepts discussed in Chapters 3-5.
• Chapter 3 focuses on the bacterial composition of people with CRPS. This
chapter will provide a cursory background on the syndrome while suggesting how
the microbial communities may contribute to and possibly cause the malady. Addi-
tionally, I will discuss the results of the metagenomic study where I will show that
the bacterial community composition of CRPS sufferers differed from healthy controls.
• Chapter 4 focuses on the nucleotide composition of prokaryotes, and what fac-
tors researchers believe could influence GC-content. Additionally, I report the results
of a metagenomic study which incorporates a large number of metagenomic samples
from many varied habitats. The genetic make-up of the prokaryotes collected from
the varied habitats are compared to show that the environments influence prokaryotic
nucleotide composition.
3• Chapter 5 focuses on what measured factors (Chapter 4) could exist in an envi-
ronment that could influence GC-content.
• Chapter 6 provides overall conclusions and directions for future research.
42. Evolutionary Theory, Microbes, Metagenomics, & Sequencing
2.1 Evolutionary Theory
Those who are not evolutionary biologists tend to think that natural selection
manifests itself as organism fitness. Darwin viewed natural selection as the mecha-
nism behind evolution, and fitness as an organism’s ability to survive and transfer
their genetic material to their offsprings [24]. Evolutionary theory becomes somewhat
murkier when one considers evolution through the lens of nucleotides rather than mor-
phology and biological function. Nowhere is this more true than with microbes. How
does one view evolution – specifically for prokaryotes (Archaea and Bacteria) when
sexual reproduction is not present. Furthermore, the differences in how organisms
in the three domains of life (Eukaryotes, Archaea, and Bacteria) adapt, feed, repro-
duce, and where they reside (to say nothing about our early ability to see microscopic
organisms), made agreement on a unified evolutionary theory challenging [111].
2.1.1 Codons, Mutations, & Selection
Gene expression is the fabrication of proteins based on the reading of the genetic
blueprint (DNA). Very briefly, an initial step in how DNA becomes a protein is that
the messenger RNA (mRNA) is transcribed from DNA. The mRNA – which is a sort
of DNA "copy" – with the assistance of transfer RNA (tRNA) and ribosomal RNA
(rRNA) is translated into a protein (Figure 2.1).
Codons, Mutations, & Selection 4
5Figure 2.1: Transcription of DNA results in several types of RNA (tRNA, mRNA,
rRNA). During translation, the coding template (mRNA) with the assistance of
rRNA and tRNA are employed to make a protein.
A protein is a molecule formed by one or multiple amino acids. Amino acids are
made up of three nucleotides or a codon. Since there are four nucleotides (adenine,
thymine, guanine, and cytosine), and a codon requires three nucleotides, there are
64 (43) possible combinations. Yet, when we look at amino acid charts, there are 20
amino acids depicted. The issue can be illuminated when one realizes that several of
the amino acids can be constructed multiple ways (Figure 2.2). A system arranged
in a redundant manner allows for mutations to occur without altering the produced
amino acid.
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Figure 2.2: Codon Construction Wheel. Starting from the inner-most circle and walking to the
perimeter of the outer circle reveals the construction of an amino acid. For example, Glutamine
(Q) can be made by CAA or CAG. IUPAC Abbreviations: A - Alanine, R - Arginine, N -
Asparagine, D - Aspartic acid (Aspartate), C - Cysteine, Q - Glutamine, E - Glutamic - acid -
(Glutamate), G - Glycine, H - Histidine, I - Isoleucine, L - Leucine, K - Lysine, M - Methionine*, F
- Phenylalanine, P - Proline, S - Serine, T - Threonine, W - Tryptophan, Y - Tyrosine, V - Valine,
B - Aspartic acid or Asparagine, Z - Glutamine or Glutamic acid. *Start codon, † Stop codon
7There are many types of mutations. As alluded to previously, silent or synonymous
mutations occur when a single nucleotide is changed to a different nucleotide without
altering the produced amino acid. These point mutations are common in the 3rd
codon position. However, point mutations which alter the amino acid are called non-
synonymous mutations. Additional mutations occur when a nucleotide is removed
or added. These insertions or deletions (i.e. indels) can greatly affect not only the
translated protein, but also the chance that the protein will be able to function.
Organisms that do not survive the indels have no fitness and have been subjected to
selective pressure. The selective pressure and the organism’s response to said pressure
will determine whether a mutation will remain in the population. While most would
agree that mutation is the source of evolution and diversity, additional items such
as horizontal gene transfer, symbiosis, and population size contribute significantly to
diversity, mutation rates, and the probability that a new mutation will persist [47].
2.1.2 Lateral Gene Transfer
As mentioned at the beginning of this chapter, bacteria and archaea are collec-
tively known as prokaryotes. Prokaryotes, unlike eukaryotes do not reproduce sexually
[111, 137]. Left with mutations and vertical gene transfer, one would expect the vari-
ability found in these domains to be somewhat meager. However, their level of genetic
variation is nothing short of astounding due to mechanisms called horizontal/lateral
gene transfer. These mechanisms work in the following ways: by conjugation – where
two prokaryotes couple and directly transfer genetic material from one organism to
another, by prokaryotes uploading DNA from their environment (i.e., from lysed cells)
into their cells, or by infection where bacteriophages (viruses which infect prokary-
otes) inserts their DNA into the host cell [137]. This type of genetic acquisition is
so pronounced – not only between similar species, but also across the phylogenetic
8spectrum – that it is thought to be responsible for much of the observed prokaryotic
variation [111, 137].
2.2 An Introduction to Microbes
2.2.1 The Importance of Microbes
Much of our early exposure to prokaryotes – and microbes in general has been
formed through the lens of decay and disease. Microbes show enormous diversity –
not only in their their physical shape, genome size, nucleotide composition, adaptive
skills, and habitat, but also their community role. We have yet to identify all mi-
crobes and we are still learning about the many sophisticated methods which have
allowed microbes to evolve and survive. The influential role that microbes play in
our everyday lives and the symbiotic relationship they have with other microbes in
their environment are instrumental in numerous global processes, bioremediation, and
contribute to other areas such as guiding the development of a functional immune
system...one could call them the engines of the planet.
2.3 Microbiome & Experiments in Metagenomics
Metagenomics is an emerging field that has revolutionized how microorganisms
are perceived and studied. In the past, scientists gleaned the majority of their knowl-
edge from bacteria that could be cultured in a lab [55]. However, it was discovered
that the majority of microorganisms could not be grown outside of their environment
in a pure culture. While the reasons behind prokaryotic resistance to culturing vary,
microbiologists began to realize their previous approaches had caused them to over-
look the existence of many microbes [62]. The understanding that these entities could
only flourish in their natural environments led to Metagenomics; the study of genetic
materials obtained directly from environmental (uncultured) communities that con-
9tain a sundry population of organisms. Although this approach requires sophisticated
computational tools, it obviates the need for specimen isolation and cultivation. As
a result, in recent years several large-scale metagenomic projects have been initiated
to investigate gene sequences in the sea floors, animal guts, and soil to name a few
[16]. Information obtained from these studies has been used in an attempt to uncover
the intricacies of microbial interactions, evolution, and the influence these organisms
have on the world as we know it.
A community receiving much attention is the one residing on the human body.
The human microbiome consists of all the genomes from microorganisms that reside
on their human hosts. The entire number of cells within the human microbiome is
reported to be 10-fold the number of human cells in the human body [54, 126]. In
an attempt to gain insight into microbial evolution, diversity and function, numerous
studies have been initiated to discover new microbes, catalogue what microbes are
present, correlate how their host’s environment impacts microbes and, conversely, how
microbes influence their environment [54, 126]. Using new sequencing technologies,
researchers have endeavored to classify bacteria in environments like the oral cavity,
skin, lungs and the GI tract. These results have been used to investigate whether
or not there exists a core community of microbes shared by all humans, ascertain
if there are microbial community differences between environments, as well as how
these communities direct health and how these communities differ in the face of
disease [54, 126, 140].
2.3.1 Sequencing Methods: 16S Sequences & Whole Shotgun Sequences
Current efforts to analyze microbes have shifted from an isolation-culture approach
to collectively analyzing the microorganisms in an environment. Today two promi-
nent non-cultured methods are small subunit ribosomal RNA and shotgun studies
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[41, 118]. In bacteria, using the 16S rRNA gene has been considered the gold stan-
dard for microbial analysis. The gene is involved in translation and as a result, it can
be found in all bacteria and archaea. The 16S rRNA gene is comprised of approx-
imately 1600 nucleotides and contains regions of variability and conservation [94].
The areas of conservation allow researchers to design primers that will recognize all
bacteria while the areas of variability provide information about the bacteria’s phy-
logenetic information [54, 94]. Targeting one gene (i.e., 16S) rather than multiple
genes is considerably cheaper, provides phylogenetic information about the sequence,
and permits diversity comparisons between samples from different environments or
subjects. However, there are biases to this approach as the primers only target the
16S gene of prokaryotic microbes (e.g., it does not capture microbes lacking a 16S
rRNA gene – like viruses or eukaryotes), and it is not possible to recover functional
information about other genes within the sample(s). Shotgun sequencing attempts to
retrieve DNA from entities contained in the sample and does not include the biases
incurred by 16S analysis. Additionally, analysis of shotgun sequenced data can pro-
vide information about bacterial, archaeal, eukaryotic, and viral domains, as well as
what genetic functions exist in the samples [16, 54, 94]. The disadvantage of shotgun
sequences is that the associated costs can be prohibitively expensive, though each
year has seen a drop in pricing (Table 2.1 [63, 136]).
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Table 2.1: The cost of NGS sequencing from 2004-2015 by Cost per Megabase of
DNA Sequence (cost of determining one million bases (Mb) of DNA and Cost per
Genome (cost of sequencing a human-sized genome).[136]
Date Cost per Mb Cost per Genome
Jan-04 $1,598.91 $28,780,376
Jan-05 $974.16 $17,534,970
Jan-06 $699.20 $12,585,659
Jan-07 $522.71 $9,408,739
Jan-08 $102.13 $3,063,820
Jan-09 $2.59 $232,735
Jan-10 $0.52 $46,774
Jan-11 $0.23 $20,963
Jan-12 $0.09 $7,666
Jan-13 $0.06 $5,671
Jan-14 $0.04 $4,008
Apr-15 $0.05 $4,211
2.3.2 Analyzing NGS Data
16S rRNA Analysis Approaches
While there are several 16S rRNA analysis methods available, there is no one
agreed-upon approach. Analysis steps are often determined by what hypothesis the
investigator would like to test. As common inquiries involve diversity assessment
between two populations, methods related to this goal fall into two basic categories:
Taxon-based analysis and phylogeny-based analysis – though information obtained in
the taxon-based analysis is used in the phylogeny-based analysis (Figure 2.3).
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Figure 2.3: Processes affiliated with 16S rRNA Analysis.
Once the data are available, there are several pre-analysis steps that should be
implemented. Because the accuracy of taxonomic assignment rests heavily upon the
length of a sequence, reads below a certain length (e.g., <200 nucleotides) should
be excluded [54]. Sequences should also be filtered for chimeras, homopolymers, and
ambiguous bases [98]. Excluding sequences with low quality scores and noise should
also be considered as their inclusion can drastically alter results [103].
Assigning operational taxonomic units (OTU) to sequences is a necessary step
in both taxon-based and phylogeny-based analysis. Clustering sequences into OTUs
greatly speeds up the classification processing by classifying or aligning a representa-
tive sequence from each cluster rather than all the sequences within the dataset. How
stringently the sequences are assigned to a cluster depends on which phylum level is
being investigated for diversity. Similarities of 95% and 97% are generally accepted
for taxonomic assessment of genus-level and species-level, respectively [54, 94].
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Taxon-based Analysis
Information pertaining to the OTUs (total number of OTUs, number of unique
OTUs) in each population/sample can be used to calculate alpha diversity. There
are several metrics available – Shannon Index, Chao Index, and the alpha rarefaction
curve are the most common. The Chao and Shannon indices are measures of species
density or richness and diversity. The rarefaction curve represents an estimate of the
expected maximum richness based on the number of sequences [54].
Cluster representatives are classified – generally implementing either BLAST (Ba-
sic Local Alignment Search Tool) or RDP (Ribosomal Database Project) [18]. BLAST
classifies sequences constructed on alignments while RDP incorporates probability-
based frequency analysis.
Phylogeny-based Analysis (PBA)
As opposed to taxon-based analysis, PBA is used to compare the diversities of
one environment to a different environment by looking at the sequences from an
evolutionary standpoint. Phylogenetic analysis requires sequences to be aligned. The
NAST algorithm aligns a representative from each OTU to a reference database (e.g.,
Greengenes) which contains pre-aligned classified sequences [26, 27]. The aligned
query sequences are then used to create a phylogenetic tree. A distance matrix of
similarity/dissimilarity is calculated from the tree and along with OTU tables can
be used to visualize how microbial communities from different environments cluster
together (Figure 2.4 bottom right) [74, 101].
Shotgun Sequencing Analysis Approaches
Many of the steps outlined in the 16S rRNA analysis are similar. There are several
approaches which can be employed to classify the sequences in order to determine who
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Figure 2.4: Typical analysis output for 16S rRNA studies. Top left: Number of
OTUs and estimators of sequence diversity and richness. Bottom left: Trees based
on sequence alignment. Top right: Relative abundance graph of identified phyla.
Middle right: Alpha rarefaction curves. Bottom right: Graph of Principle
coordinates analysis (PCoA).
is there. Determining taxonomy diversity can be done using marker genes, binning,
and assembling (mapping) sequences to a referential genome [118]. To determine
the biological function of the metagenomic community, sequences can be annotated
to determine the coding regions [118]. By mapping and/or comparing the protein
sequences to referential protein sequences, one can infer biological function.
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3. Complex Regional Pain Syndrome
3.1 Introduction
Complex Regional Pain Syndrome (CRPS) is a serious and painful condition that
generally develops after an inciting event such as injury, illness or surgery and cannot
be explained by another medical diagnosis. The array of symptoms that accompany
this condition can be classified into four main categories: abnormal pain processing,
vasomotor changes, trophic changes, and impaired motor functions [4, 56, 115]. Each
category contains multiple indications which a person may exhibit individually or
in concert with other symptoms. While those with CRPS present similar categorical
traits, the arrangement and degree to which these symptoms are expressed vary across
the population resulting in the creation of disease subsets [5]. Additionally, there is no
one specific therapy that wholly addresses the effects of this varied condition [5, 52].
There is evidence that early recognition and treatment of CRPS increases the chance
of recovery – though current treatments are largely ineffective [52, 132]. Although
the mechanisms behind CRPS have not been fully identified, research has shown that
neurogenic inflammation plays a significant role and appears to be modulated by both
the central nervous and immune systems [4, 52, 78, 114].
3.2 Background
3.2.1 The Importance of Gastrointestinal Bacteria
The GI bacterial community is purported to contain on the order of 1013 - 1014
organisms, harbors approximately 1,000 different species, and is considered to have
the most diversity among other human-host environments such as the skin and oral
cavity [62, 98, 103, 112, 124, 127]. Bacteria within the gut are vital to nutrient
The Importance of Gastrointestinal Bacteria 15
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breakdown and absorption; they prevent colonization of pathogens, can metabolize
toxins on a scale equal to that of the human liver and provide a structural backbone
to a functional immune system [19, 66, 76, 109]. As such, bacteria and their ability
to influence human health has been the focus of many human microbiome studies.
To date, many of these studies have attempted to ascertain the constituents of
a healthy GI microbial community or to describe community differences in the face
of diet differences, obesity, antibiotic usage, colon cancer, or inflammatory bowel
diseases (IBD) [29, 37, 72, 77, 120].
3.2.2 Maladies & Microbial Communities
The prevailing belief is that a GI system housing an unbalanced microbial com-
munity leads to health issues involving inflammation [109]. While it seems intuitive
that GI bacteria can be correlated to GI maladies, there are a number of studies
that have found a link between GI bacteria and behavior, stress, depression, sickness
response, and pain perception [12, 20, 42, 45, 97, 133]. Of particular note, Amaral
demonstrated that GI bacteria could influence how rodents perceived pain that was
located at their extremities [6].
3.2.3 Immunology & Microbial Communities
The GI epithelial layer forms the main defense against pathogenic and undesirable
bacteria intrusion into the human body. The epithelium is continually regenerated
/shed and protected by a mucosal buffer. Processes of dendritic cells from the GI tract
extend through the epithelial layer. The cells are directly stimulated during contact
with microbes signaling the human body to develop appropriate immune responses
[20, 76, 109]. The presence of bacteria in such close proximity to the epithelial layer
is a likely contributor to GI lymphoid tissue (which constitutes 70% of immune cells)
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[127]. This interaction spurs the production of luminal secretions of antimicrobial
proteins via B lymphocytes and plasma cells [20, 60]. Studies on germ-free mammals
have shown that without the proper stimulus, the body when introduced to pathogens
is incapable of mounting an appropriate combative response [45, 60]. In gnotobiotic
studies of mice and zebrafish, researchers have found that microbial absence led to
modulated cytokine production, reduced epithelial mucosal integrity and defects in
’gut-associated lymphoid tissue’ [102, 109, 116]. Along the GI tract, dendritic cells
are directly stimulated by contact with microbes, prompting the body to develop an
immune response which includes the release of cytokines [20, 76, 109].
3.2.4 CRPS & the Gut-Brain Axis
The gut-brain axis is a bi-directional communication network involving the sympa-
thetic, parasympatheic, and enteric systems [11, 20, 22, 80]. There is a perpetual flow
of information about bodily performance that is acquired by the brain and used to
maintain homeostatic levels - among them the digestive and "gut-associated immune"
systems [80]. Sensory signals are carried by the enteric, spinal, and vagal pathways.
Of particular note is the vagus nerve which is in contact with processes of dendritic
cells that extend through the epithelial layer of the GI tract [20, 76, 109]. This nerve
carries signals to the CNS and is essential in regulating emotion, pain, and immune
response [20, 76, 80, 109, 133]. It has been named in the immune-to-brain pathway,
and has been associated in the development of sickness responses [20, 76, 80, 109, 133].
Molecules involved in the transmission of information include cytokines, hormones,
endotoxins, and neuropeptides [11, 133].
Under healthy circumstances, interoceptive information is not generally perceived
consciously. However in persons experiencing functional abdominal pain syndrome,
they are keenly aware of this transmission and experience extended pain/discomfort
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[80]. It has been suggested that these pain states result from dysregulated interactions
between the gut lumen and mucosa, the enteric nervous system, and the central
nervous system – all culminating in modification of affect, perception, GI motility,
and in certain conditions, immune function [80].
3.2.5 Targeting Bacteria
In order to identify the bacterial communities of each sample, this study tar-
geted the 16S rRNA (small subunit ribosomal RNA) gene. The gene is comprised
of approximately 1600 nucleotides, with conserved and variable regions [94]. The
conserved areas allow researchers to design primers that will recognize all bacteria
while the areas of variability provide valuable phylogenetic information [54, 94]. For
this investigation, bacterial sequences were procured with 454 sequencing technology
using primers directed at the V2 conserved region of the 16S rRNA gene.
3.3 Methods
3.3.1 Subject Selection
The CRPS gut study was undertaken at Drexel University College of Medicine
(DUCOM) in Philadelphia PA and was approved by the Internal Review Board (IRB).
Sixteen CRPS subjects and 16 healthy controls were enrolled in this study. Informed
consent was obtained from all subjects prior to their participation. As CRPS is
approximately four times more prevalent in women than men, only women were re-
cruited for this investigation [25, 115]. Subjects with CRPS (CRPS_All n = 16) were
recruited from the DUCOM Pain Clinic and met the International Association for the
Study of Pain (IASP) diagnostic criterion for CRPS [56]. Of the 16 CRPS subjects,
14 of them were classified as having Type I CRPS. A subset of the CRPS population
(CRPS_GI n = 5) experienced gastrointestinal discomforts (e.g., pain, constipation,
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diarrhea) but did not have a diagnosis of IBD or other GI disorders. Participation
was offered to patients using the following inclusion criteria: 1) female; 2) 20-55
years of age; 3) physician diagnosis of CRPS I or II; 4) willingness to complete a
self-administered written survey; 5) a willingness to provide a fecal sample; 6) reside
within the Philadelphia region; and 7) exercise non-vegetarian eating habits. Exclu-
sion criteria included: 1) the inability to complete the questionnaire; 2) other serious
medical conditions; 3) use of antibiotics, narcotics or colon cleansing within 3 months
prior to sample collection; and 4) women who had hysterectomies, were pregnant or
were on hormone replacement regiments. The control subjects (n = 16) consisted of
healthy females with no medical conditions and with the exception of having a pain
diagnosis, adhered to the same participation requirements as the CRPS population.
In addition to collecting a fecal sample, all participants completed a standardized
questionnaire constructed for this study that captured self-reported demographic in-
formation, a history of medical diagnoses (including age of onset of their symptoms
and age of their diagnosis by a physician), medication and/or nutritional supplement
usage, and a synopsis of their typical food and drinking habits.
Separation of CRPS into Sub-Groups
Because it is known that people with GI maladies exhibit distinct microbial com-
munities, the CRPS group (CRPS_All) was often split into two sub-groups; those
with GI issues (CRPS_GI) and those without GI issues (CRPS_NOGI). The rea-
soning behind this approach was to ensure that those with GI complications were not
the driving force behind any differences found between the CRPS_All group and the
Control group.
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3.4 Sample Collection and Transport, DNA Extraction and Sequencing
Fecal samples were used in order to determine if the GI microbial communities
of CRPS subjects differed from those of healthy controls. To ensure that this study
was comparable to other studies, the protocol employed by the Human Microbiome
Project was mimicked [49, 93]. Fecal samples were collected by study participants in
their homes. Collected samples were placed in a stool specimen container and imme-
diately placed under anaerobic conditions, stored in a cooler at −4◦C and transported
at 4◦C to the laboratory within 24 hours. Once in the laboratory the samples were
weighed, partitioned into shipping and storage tubes and stored in a freezer at −80◦C.
Analysis samples were shipped overnight express with dry ice to the Research Testing
Laboratories (Lubbock, TX) for sequencing. Methods for DNA extraction, amplifica-
tion, and 454 sequencing follow those referenced in a recent publication by Finegold
et al. [42].
3.4.1 Sequence Processing Pipeline and Microbial Analysis
The microbial analysis was performed using command-line versions of Qiime (Quan-
titative Insights Into Microbial Ecology) and RDP (Ribosomal Database Project)
[14, 18, 131]. Qiime consists of it’s own, as well as numerous third-party tools, de-
signed to compare and analyze microbial communities [27, 39, 53, 73, 91]. Within
this frame-set, users are free to tailor their analysis by selecting which tools are used
and by tuning the tool’s parameters. Qiime incorporates the RDP classifier but not
RDP’s library comparison tool. The 454 sequences were processed and analyzed in
an Unix-environment.
Prior to analyzing the dataset, sequences were inspected to ensure proper label-
ing (barcoding) [91]. After the mapping check, the dataset was filtered to remove
sequences <250 nucleotides or >850 nucleotides in length. Reads with poor quality
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scores (<25), ambiguous bases, mutations in primers and barcodes, or reads contain-
ing more than 6 homopolymers (e.g., six or more repeats of a particular nucleotide)
were also excluded from further analysis.
Sequences were subsequently sorted in order of decreasing length and clustered at
97% identity to establish the operational taxonomic units (OTUs) using Uclust and
Cd-hit [39, 73]. Although there are known discrepancies, sequences grouped together
at 3% divergence are generally accepted as belonging to the same species during
taxonomic classification [94].
Representatives from each OTU were aligned with PyNAST using the Green Genes
pre-aligned core set as a template and a Lane mask [27, 69]. ChimeraSlayer was run
on the aligned sequences to identify and remove any sequences generated by PCR
error (i.e., chimera) [53].
Two non-parametric estimators were used to investigate the richness and diversity
of a sample. The Chao1 Estimator and the Shannon Index are common ecological
tools employed to look at a population’s variation and diversity [15, 117]. The Shan-
non Index uses the abundance of each species to determine the sample’s diversity
while the Choa1 Estimator uses the number of OTUs, the number of OTUs contain-
ing only one sequence, and the number of OTUs with only two sequences to assess
the sample’s richness.
Rarefaction curves, which are graphical representations of diversity were generated
by randomly selecting a particular number of sequences from a group’s sample set
and determining the number of species (OTU’s) found within that set. This process
was repeated 100 times (with replacement) and the resulting average values were used
to create a rarefaction plot.
OTUs were assigned to a taxonomy with the RDP Classifier at ≥80% bootstrap
support [13, 27, 131]. After taxonomic classification, the cohort of samples belonging
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to the same group (e.g., CRPS, Control) were combined into a single library. Library
compositions were compared between the Control and CRPS groups using RDP’s
Command-line Library comparison tool. This tool calculates the probability of the
observed frequency differences between libraries given equal frequencies within the
two studied libraries.
In order to visualize possible sample separation, Principle Coordinate Analysis
(PCoA) using an unweighted UniFrac distance matrix was employed [74, 101]. PCoA
belongs to a set of clustering methods which uses a distance matrix to describe all the
samples within the dataset. This matrix is used to calculate the principle dimensions
which depict the differences between members from separate categories (e.g., study
groups). PCoA organizes the dimensions to be those that best discriminate between
the specified categories and not just between individual samples.
3.4.2 Statistical Analyses
Statistical analyses were performed using the statistical package SPSS (version
19) [121]. When computing the differences between two groups, the Student’s t-test
was used. To assess significant differences between more than 2 groups, analysis
of variance (ANOVA) was used. In order to determine if a particular factor (e.g.,
disease state, age, BMI, medication) had a significant association with the PCoA
axes, multivariate analysis of variance (MANOVA) was performed on the first three
PCoA tables using Pillai’s criterion (Table 3.1). Univariate ANOVA was run on any
significant MANOVA results to show which axis was influential in the PCoA plots
(Table 3.1). For all types of analyses, significance was defined at p ≤ 0.05.
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Table 3.1: The p-values from MANOVA (a) and ANOVA (b) analyses on PCoA
axes. Analyses incorporated an UniFrac distance matrix and environmental
characteristics of the sample’s subject.
Source of variation Pillai’s trace Hypothesis d.f. Error d.f. F P
a) Multivariate Analysis
CRPS_NOGI, CRPS_GI & Controls 0.189 6 56 4.401 0.001
CRPS_All & Controls 0.508 3 28 9.647 0.000
Age 0.251 9 84 0.852 0.571
BMI 0.149 6 56 0.751 0.611
Type III SS d.f. F P
b) Univariate Analysis
CRPS_NOGI, CRPS_GI & Controls
PCoA1 0.402 2 18.298 0.000
PCoA2 0.012 2 0.313 0.734
PCoA3 0.27 2 0.956 0.396
CRPS_All & Controls
PCoA1 0.296 1 23.76 0.000
PCoA2 0.018 1 0.738 0.401
PCoA3 0.002 1 0.122 0.731
3.5 Results
3.5.1 Subject Demographics
A total of 32 subjects (16 CRPS (5 with intestinal discomforts), 16 controls) were
enrolled in this study. All CRPS subjects were recruited from the DUCOM pain
clinic and met the IASP criteria for CRPS. Clinical examination revealed irregular
pain processing in all subjects; the most pronounced symptom was mechano allodynia.
Of the 16 subjects, 14 were classified as having Type I CRPS. All participants were
white females, between the ages of 23-51 residing in the Philadelphia region. The
most common medications taken by the CRPS study subjects were anti-epileptics
(63%), antidepressants (57%), and anti-anxiolytics (31%). The number of subjects
in each group, their age, body mass index, and their pain levels and disease duration
(when applicable) can be found in Table 3.2. Using the Student’s t-test, no significant
differences in BMI or age (df = 30, p > 0.05) were found.
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Table 3.2: Characteristics of study participants (N) in each group at time of
sampling. The mean and range of age and disease duration are given in years. The
mean ± the standard error is given for the body mass index (BMI).
CRPS_NOGI CRPS_GI CRPS_ALL Controls
Group Size 11 5 16 16
Age Years (Range) 40.45 (23-51) 37.20 (31-49) 39.44 (23-51) 35.63 (24-49)
BMI 25.70±1.65 24.10±1.37 25.19±1.21 23.68±0.70
Disease Duration (Range) 4.82 (1-12) 7.00 (1-11) 5.50 (1-12) NA
Pain Level (Range) 5.2 (3-8) 5.9 (3-8) 5.7 (3-8) NA
3.5.2 Sequence Processing
At total of 180,896 sequences were returned from Research Testing Laboratories.
Post filtering, the dataset consisted of 96,224 sequences with an average number of
sequences per participant at 3,007 (range 1,484 - 9,767). After chimera removal,
the dataset consisted of 88,958 sequences. On average, the number of sequences per
participant was 2,505 (range 1,308-9,157) (Table 3.3).
3.5.3 Sample Diversity
The Choa1 Estimator and Shannon Index were the two non-parametric estimators
used to investigate the richness and diversity of each sample. Information about the
number of sequences, OTUs, the diversity assessment, and their mean values are
in Table 3.3. The mean values for OTUs, Chao1 Estimators, and Shannon Indices
were lower in all CRPS groups when compared to the Control group. T-test results
between the CRPS_All and the Control group yielded significant differences in both
the number of species (OTUs) (df = 30, p ≤ 0.05) and the Chao1 Estimator (df = 30,
p ≤ 0.05). Near significance (df = 30, p < 0.1) can be seen in the Shannon (diversity)
Index.
Interestingly, when we divided the CRPS subjects into two groups; those with
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Table 3.3: Characteristics of study participants (N) in each group at time of
sampling. Mean values for number of sequences, OTUs (grouped at 97 % (species
level)), richness estimator (Chao1) and diversity (Shannon) index for each group are
also listed. Mean values for Chao1 Estimator and Shannon Index are accompanied
by the ± standard error of their means. Assuming equal proportions of each OTU,
the maximum possible Shannon Index is 8.23.
CRPS_NOGI CRPS_GI CRPS_ALL Controls
Sequences (Range) 2819.27 (1853-4787) 1857.20 (1581-2235) 2519.25 (1581-4787) 3040.63 (1308-9157)
OTUs (Range) 280.45 (195-392) 203.20 (116-272) 256.31 (116-392) 328.63 (145-591)
Chao1 Estimator 520.76±44.18 400.27±40.06 483.10±35.16 651.75±54.12
Shannon Index 3.89±0.15 3.65±0.19 3.82±0.12 4.12±0.12
intestinal difficulties (CRPS_GI) and those without (CRPS_NOGI), diversity mea-
sures remained lower than the controls while maintaining no significant differences
between the two CRPS sub-populations.
Rarefaction curves assembled from combined datasets can be seen in Figure 3.1.
The curves indicate that as the number of sampled sequences increases, the Control
group consistently scored the highest number of species. Within the CRPS_All group,
the CRPS_NOGI group contained a greater species richness than the CRPS_GI
group. That each curve continues to increase and has not begun to plateau suggests
that not all species have been discovered and more reads should be obtained during
the sequencing process [57]. However, this should not obviate the result of higher
species occurrence reported in the Control group.
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Figure 3.1: Rarefaction analysis of V2-targeted pyrosequenced reads of the bacterial
16S rRNA gene recovered from human fecal specimens. The rarefaction curves were
constructed at 97% (species level) sequence similarity and were pooled together
according to disease group specification.
3.5.4 Compositional Classification and Comparison
A breakdown of each study group at the phylum level can be seen in Figure 3.2.
The Control group had the highest proportion of the Firmicutes phylum at 64.8%
(CRPS_All 46.21%, CRPS_GI group 51%, CRPS_NOGI group 44%). Variation in
the proportion of Proteobacteria between the two groups was also pronounced. Pro-
teobacteria contribution percentages were 0.078% for the Control group and 7.02% for
the CRPS_All group (CRPS_GI 11.3%, CRPS_NOGI group 5.1%). T-test p-values
were found to be significant for Firmicutes and Proteobacteria phyla (df = 18.97, p ≤
0.05 and df = 15.68, p ≤ 0.05 respectively, equal variance not assumed). These results
indicate a structural difference in the make up of the bacterial communities between
the Control and all CRPS groups. In order to determine if this conclusion was well
27
founded, RDP’s Command-line Library comparison tool was used [18]. This tool cal-
culates the probability of seeing the occurrence rate of a given taxon in one library
appearing at the same frequency in a second library. When compared to the Control
group, CRPS groups were found to have significantly distinct representations of Bac-
teroidetes, Firmicutes, Fusobacteria, Proteobacteria, Actinobacteria, Synergistetes,
and Verrucomicrobia phyla (p << 0.01).
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Figure 3.2: The relative abundance of the bacterial composition, seen at the phylum
level. Participants with CRPS show a reduction in Firmicutes and increased levels
of Proteobacteria. The CRPS_GI (n=5) contains CRPS subjects that expressed GI
issues, the CRPS_NOGI are comprised of CRPS subjects sans GI complications,
the CRPS_All group is a cohort of all the CRPS subjects. Verrucomicrobia appears
elevated in the CRPS groups, however the Student’s t-test did not produce
significant results. Further inspection revealed the phylum’s increased levels can be
attributed to a few CRPS subjects.
The probability of seeing a particular bacterium occur at the same rate in two
study groups was assessed using RDP’s LibCompare tool. The microbial libraries
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were significantly different (p << 0.01) in the Actinobacteria, Bacteroidetes, Firmi-
cutes, Fusobacteria, Proteobacteria, Synergistetes, and Verrucomicrobia phyla be-
tween CRPS subjects and healthy controls (Table 3.4).
Table 3.4: The Student’s t-test p-values between CRPS_All and Controls of raw
abundance at the phylum level (left). Equal variance is assumed unless noted by an
asterisk (*). Results from RDP’s command-line Library Comparison Tool p-values
between CRPS_All and Controls of raw abundance at the phylum level (right).
Bolded values indicate significance (≤ 0.05).
Phylum Student’s RDP Library
t-test Compare Tool
Firmicutes* 0.017 0.01
Bacteriodetes 0.654 0.01
Proteobacteria* 0.043 0.01
Verrucomicrobia* 0.185 0.01
Other 0.494 0.01
Actinobacteria 0.621 0.01
Fusobacteria 0.403 0.01
Cyanobacteria 0.489 0.43
Synergistetes* 0.333 0.01
Tenericutes* 0.333 0.08
3.5.5 Bacterial Community Structure Comparisons
In order to visually inspect how samples clustered together, PCoA (unweighted
UniFrac matrix) was implemented. When samples where assessed by other patient
characteristics (e.g., age, BMI, disease duration, pain status, medication), the only
identifiable delineation occurred when samples were analyzed according to disease
state (e.g., CRPS, Control) (Figure 3.3). In Figure 3.3, the Control group clusters
more closely than CRPS subjects, indicating a similarity in the group’s microbial
structure. P1 vs P3 captures a slight clustering of CRPS_GI subjects, demonstrating
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that there may be something distinct about this sub-population.
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Figure 3.3: Principal coordinates analysis (PCoA) generated from the unweighted
UniFrac matrix of OTUs of CRPS subjects with gastrointestinal difficulties
(CRPS_GI, n=5), CRPS study participant’s with no gastrointestinal difficulties
(CRPS_NOGI, n=11), and health controls (Controls, n=16).
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3.6 Discussion
Although the pathophysiology of CRPS is not completely understood, it is thought
to include a maladaptive response to nervous system damage involving immune and
inflammatory pathways [21, 133]. Converging evidence identifies the role of the im-
mune system as a contributor to the development and continuation of chronic pain
[21, 133]. As GI bacteria have a profound effect on the functioning of the immune
system, this study investigated whether differences existed in the bacterial commu-
nities in healthy controls and CRPS sufferers. There was no significant difference in
age or BMI between the study groups.
Following the Human Microbiome Project protocol, fecal samples were used to
study GI microbial communities. Bacteria DNA was extracted from fecal samples
of 16 healthy controls and 16 CRPS subjects (5 with mild GI distress) by targeting
the V2 region of the 16S rRNA gene. It is important to note that the differences
between controls and CRPS participants are present in each type of microbial analysis:
diversity, taxonomic, and spatial clustering.
CRPS subjects were found to have lower levels of diversity than their healthy
counterparts. The CRPS_All group (as well as CRPS sub-groups) had significantly
less species than the Control group. Rarefaction curves indicate that more species
remain to be found but were congruent with diversity metrics and showed a reduction
in the number of species in the CRPS_All group when compared to controls. It is
unclear whether the gastrointestinal tract of CRPS study participants have always
contained less bacterial diversity throughout their lives, if the reduction occurred
after the development of the syndrome, or if diversity levels were a result of ingesting
medications (e.g., antibiotics) consistently at some point earlier in their lives. What
is known is that the decreased diversity of the GI microbial community has long
been marked by GI inflammation, damage to the mucosal cover of the GI epithelium
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and uncontrolled production of pro-inflammatory cytokines [46, 77, 109, 130]. It has
been suggested that rather than a particular pathogenic bacterium, the cause of GI
inflammation is the result of a disruption to the phyla distribution of a healthy gut
[109, 130].
The probability of seeing a particular bacterium occur at the same rate in two
study groups was assessed using RDP’s LibCompare tool. The microbial libraries
were significantly different (p << 0.01) in the Actinobacteria, Bacteroidetes, Firmi-
cutes, Fusobacteria, Proteobacteria, Synergistetes, and Verrucomicrobia phyla be-
tween CRPS subjects and healthy controls.
When viewing the relative abundance at the phylum level, the overwhelming con-
tributors were Firmicutes and Bacteroidetes which is in accordance with previous
investigations into GI community structures [37, 72]. However, the Firmicutes and
Proteobacteria contributions were significantly different between the CRPS and Con-
trol groups. It is interesting to note that CRPS subjects contained greater amounts
of Proteobacteria, which is comprised entirely of gram-negative bacteria. The cell
walls of gram-negative bacteria are primarily composed of lipopolysaccharides (LPS)
which promotes an innate immune response in humans consisting of cytokine produc-
tion and inflammation as well as a contributor of sickness response [6, 81, 92, 133]. Of
particular interest is TLR4 (Toll-like receptor), a pattern recognition receptor which
is a pivotal component of the innate immune system [6, 92]. TLR4 recognizes mi-
croorganism elements and has been associated with inflammation as a result of tissue
injury [6, 92].
PCoA plots were created using an unweighted UniFrac distance matrix based on
demographic factors. Visual inspection and MANOVA results showed sample clus-
tering structured by disease state, but not by any other group characteristics (PCoA
plots for age, BMI, disease duration, pain levels, and medication are not shown). This
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applied to when the CRPS subjects were placed into one group (CRPS_ALL) as well
as into two groups (CRPS_GI, CRPS_NOGI). In both cases, univariate ANOVA
found the PCoA1 axis responsible for the delineation of the Control and CRPS pop-
ulations. While these plots showed the Control samples as having less intra-variance,
the same cannot be said for the CRPS subject samples - although there is a slight
grouping of the CRPS_GI subjects on the PCoA P1 vs. P3 plot. There were no
significant differences in the MANOVA results within the sub-groups. This clustering
may be indicative of altered disease mechanisms. However, an increased sample size
would be required to enhance the credence of this idea, as the existing sample sizes
were too small to make overreaching conclusions.
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4. Prokaryotes & GC-content
4.1 Introduction
Of the many features that are available in the field of comparative genomics, one
of the most recognized and easiest to measure is the genomic guanine (G) and cyto-
sine (C) distribution [17, 31, 113]. The GC-content is important as it can be used
as a gross way to classify prokaryotes and is reflective of the evolutionary history of
the prokaryote as well as it’s adaptive disposition to it’s current environment [113].
The GC abundance within prokaryotic genomes is highly diverse and can range from
∼13% to ∼75% GC [3, 44, 59, 100]. It was widely assumed that this expanse of varia-
tion was due to differences in the mutational biases of individual prokaryotic species.
However, as DNA mutations have been shown to always be biased towards adenine &
thymine, prokaryotic GC-variation cannot be explained by different mutation biases
of individual species [58, 59]. This necessitates an alternative explanation for the
existence of many GC-rich and GC-intermediate genomes. Several studies have in-
vestigated whether certain factors provoke distinct GC-levels. Correlations between
genome size, higher gene expression levels, aerobiosis, environmental temperature,
radiation levels, the presence of exogenous entities, and GC-content have been noted
[9, 79, 82, 84, 84, 87, 88, 100, 138]. However, many of the explanations have been
mired in controversy and the true source of GC-diversity within prokaryotic genera
remains inconclusive [3, 17, 44, 58, 59]. It is likely that the key to understanding the
variability seen in prokaryotic genomes is not one, but rather the amalgamation of
multiple factors.
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4.2 Another Explanation for Variation in Prokaryotic GC-Content
Unlike studies that tended to select singular traits such as genome size or ther-
mophiles to explain GC-content, this study suggests that the environment is another
explanation for the variation seen in GC-content. As opposed to many studies which
used fully-sequenced genomes to make their ascertations, this study employed shotgun
sequences. Fully-sequenced genomes provide an abundance of information about the
organism, but using the GC-content of a fully-sequenced genome suggests that there
will never be alterations to the genetic code. By utilizing metagenomic sequences the
allusion is this: let’s take classified sequences from the same phylum but different
environments and look at whether or not their genomic composition differs. If there
was a difference, one could conclude that there was something in those environments
that was the influencing factor.
Foerstner et. al., had a similar idea published in 2005 [44]. They calculated
the GC-content for each sample (farm soil, deep-sea whale carcasses, biofilm from
an underground acid drainage mine, and surface sea water), and found that each
environment had a distinct GC-signature. They also classified each of the sequences
and calculated the relative abundance of each phylum. After which, they downloaded
all of the fully-sequenced genomes (n=162) and calculated the collective GC-content
for each phylum. Using the GC-content of the phylum of fully-sequenced genomes
combined with relative abundance of each phylum in the samples, they came up with
an expected GC-content – which differed from the actual GC-content.
The work that follows builds upon the work of Foerstner et. al.. However, this
work utilizes a far greater number of metagenomic samples from a myriad of en-
vironmental categories (n=14, e.g., soil, fish slime, human gut, marine water, etc.)
as opposed to the four environments used from Foerstner et. al.. Furthermore, the
work presented here using multiple samples from a single environmental category to
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assess the range, variation, and characterization of the genetic composition of the
prokaryotes within those samples. Lastly, this work incorporates correlations and
other statistical methods to assess compositional similarities and relationships.
4.3 Material and Methods
4.3.1 Data sources
Shotgun-sequenced fasta files from numerous environments were obtained from
MG-Rast [83]. Details of each project’s methodology, metadata and geographic lo-
cation can be found here: http://simlab.biomed.drexel.edu/maps/GC_map.php
[7, 10, 28, 32, 33, 40, 65, 85, 95, 107, 123, 134, 139]. The files were downloaded at
the screened level in the analysis process, which should have excluded ambiguous
reads, short sequence reads, low quality scores, and redundant sequences. Addition-
ally, reads shorter than 100 bp were removed from consideration. The remaining
reads were then taxonomically classified (from the level of phylum to that of genus)
using the PhymmBL software [1, 2]. PhymmBL uses a combination of interpolated
Markov models and BLAST to score each metagenomic read, and has been shown
to be more accurate in classifying reads when benchmarked against the same reads
classified using only BLAST [108]. Reads classified at the phylum level with a confi-
dence score of 80% or higher were retained and then analyzed for their GC-content.
In totum, 33 unique prokaryotic phyla were identified and their relative abundance
was calculated for each dataset. Using the relative abundance, attention was focused
on the 10 phyla that consistently appeared to be most prevalent across all datasets.
These phyla included two archaea, Euryarchaeota and Crenarchaeota along with 8
bacterial phyla (Actinobacteria, Bacteroidetes, Chlamydiae, Deinococcus-Thermus,
Firmicutes, Proteobacteria, Spirochaetes, Tenericutes).
Full genome sequences and their taxonomic classifications were downloaded in
36
October 2014 from the NCBI microbial database [96]. This was to verify that the
GC-content of the shotgun data – once classified – was in agreement with the GC-
content of the referential (fully-sequenced) phyla.
In order to examine the levels of sequence variation of orthologous protein pairs
within each phylum the POGO database was used [68].
4.3.2 Assessing Genus Level Similarity between Environments
In order to assess how similar two environments were in the identities of the genera
they contained, sequences within each environment were classified at the genus level.
A list was then created for each environment which contained all of the present genera
within that environment. The similarity of different environments was assessed by
calculating the Jaccard similarity coefficient. This coefficient is defined as the union of
the two sets (how many genera are contained within the two environments together)
divided by the intersection of the two sets (how many genera are shared by the two
environments) (Equation 4.1) [71].
Jaccard(EnvironmentA, EnvironmentB) =
|EnvironmentA ∩ EnvironmentB|
|EnvironmentA ∪ EnvironmentB|
(4.1)
4.3.3 Annotation of protein-coding genes and extraction of fourfold de-
generate 3rd codon positions
Sequences with a confidence score (PhymmBL) >= 80% were run through FragGe-
neScan for gene detection [106]. Each successfully annotated sequence was examined
for the location of those amino acids with four-fold redundancies (Alanine, Arginine,
Glycine, Leucine, Proline, Serine, Threonine, Valine). The 3rd codon positions of
these codons were then extracted for GC-content calculations.
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The similarity analysis, Wilcoxon Rank Sum Test (Mann-Whitney-Wilcoxon),
and hypergeometric probability was done in Python; all other statistical analyses
were performed with the R-statistical package [99, 129].
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4.3.4 Analysis Pipeline
Figure 4.1: Steps involved in downloading data from MG-Rast (top), analyzing raw
data (middle), and analyzing annotated data (bottom). Note that the steps for
analyzing the interquartile region (IQR) data are identical to analyzing the raw
data save an additional filtration step.
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4.4 Results
4.4.1 Mean GC-content and degree of variation in GC-content vary greatly
between prokaryotic phyla
Taxonomic analysis and GC-content assessment were performed on over 31 mil-
lion sequences from 183 shotgun-sequenced metagenomic datasets, which were taken
from 14 types of environments (Table 4.1). The number of datasets along with the
raw and relative abundance of sequences for the 10 phyla which were the most abun-
dant across all environments (Material & Methods) can be seen in Table 4.1 and
Figure 4.2. Figure 4.3 contains the plots for the distribution of GC% by taxon in
each environment.
Table 4.1: Number of datasets and sequences by environment. *Number of classified
sequences
Environment Number of Datasets Number of Sequences*
Chicken Cecum 2 384,676
Contaminated Soil 3 3,654,826
Coral 7 427,591
Cow Rumen 3 490,767
Dental Plaque 8 1,725,397
Fish Slime 2 80,878
Fish Gut 2 57,122
Human Gut 111 16,047,825
Microbialites 13 515,358
Tundra 1 5,894,070
Water Marine 13 810,607
Water Mine 2 359,534
Water PondFresh 4 325,037
Water PondSaline 12 665,214
Total 183 31,438,902
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Figure 4.2: Relative abundance of each phylum within the various sampled
environments.
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Figure 4.3: GC-levels for each phylum across all environments. Values originate
from the calculated GC-content of pooled individual reads (classified to a specific
phylum) from the samples obtained from the 14 metagenomic environmental
categories. A=Actinobacteria, B=Bacteroidetes, C=Chlamydiae, D=Crenarchaeota,
E=Deinococcus-Thermus, F=Euryarchaeota, G=Firmicutes, H=Proteobacteria,
I=Spirochaetes, J=Tenericutes
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Figure 4.3 (continued)
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Based on the mean GC-content, phyla could be classified into one of three cate-
gories: GC-rich (Actinobacteria: 62.1%, Deinococcus-Thermus: 64.4%), GC-intermediate
(Crenarchaeota: 49.7%, Euryarchaeota: 53.7%, Proteobacteria: 56.4%) and GC-poor
(Bacteroidetes: 46.0%, Chlamydiae: 40.3%, Firmicutes: 43.1%, Spirochaetes: 40.6%,
Tenericutes: 32.2%). The GC composition of each phylum within the metagenomic
datasets coincided with those of the referential fully-sequenced genomes of the same
phylum (Figure 4.4)
Figure 4.4: GC vs. Phylum. GC-levels for fully-sequenced prokaryotic genomes.
Values originate from the calculated GC-content of pooled individual
fully-sequenced genomes (downloaded from NCBI as of October 2014) that were
attributed to a particular phylum.
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Levels of variation in GC-content around the calculated mean also differed greatly
among the phyla. Certain phyla showed great variability in their range of GC-levels
(e.g., Spirochaetes: ±11.8) while other phyla had moderate consistency (e.g., Tener-
icutes: ±8.9). Strikingly, Chlamydiae and Deinococcus-Thermus seemed highly im-
pervious to their surroundings and maintained a very restricted GC-composition with
a standard deviation of approximately ±5.5 and ±5.9 respectively. Whether a certain
phylum had a broad or narrow range of GC-compositions, it tended to be consistent
across environments (Figure 4.3). In other words, phyla that had a broad range of
GC-compositions in one environment tended to have a similarly broad range in all
remaining environments. Accordingly, phyla having a narrow GC-range tended to
consistently present a narrow range in the remaining environments.
The homogeneous GC-levels seen respectively within Chlamydiae and Deinococcus-
Thermus could be the result of low sequence divergence between members of these
phyla. To examine this possibility, the average amino acid identity (AAI) levels of
orthologous protein-coding genes belonging to fully-sequenced members of each phy-
lum was calculated (Figure 4.5). The AAI is the percentage of identical amino acids
used in orthologous genes between two species of prokarytes (belonging to the same
phylum).1 The plots show that for Chlamydiae and Deinococcus-Thermus, there are
numerous genome pairs that are highly diverged. Levels of divergence do not seem to
be lower for these phyla than for other phyla that have much higher GC-ranges. These
results suggest that low levels of nucleotide content variation within these lineages
are not due to low levels of sequence variation within the same lineages.
1Only species sharing at least 80% identity of the 16S rRNA gene were compared.
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Figure 4.5: Amino Acid Identity (AAI) values calculated for all genomes sharing greater
than 80% 16S identity. The values represents the percentage of identical amino acids used
in orthologous genes between two species of prokaryotes (belonging to the same phylum).
A=Actinobacteria, B=Bacteroidetes, C=Chlamydiae, D=Crenarchaeota,
E=Deinococcus-Thermus, F=Euryarchaeota, G=Firmicutes, H=Proteobacteria,
I=Spirochaetes, J=Tenericutes
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Figure 4.5 (continued)
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Figure 4.5 (continued)
4.4.2 GC-content varies across environments in a manner that cannot be
explained by differences in phylogeny
As can be seen in Figure 4.6, GC-levels vary by environment. To rule out the pos-
sibility that variation in GC-composition between environments could be explained
entirely by differences in phylogenetic composition, an investigation was done to ascer-
tain whether the nucleotide content of different phyla correlated across environments.
Such correlations would indicate that whatever force influenced the nucleotide con-
tent in one phylum also had an effect on the nucleotide content of the remaining
phyla. This would demonstrate that variation in GC-content between environmental
categories was not the sole result of distinct phylogenetic compositions in different
48
metagenomic samples. Rather, it would indicate that phyla were affected by their
environment in a correlated manner.
Figure 4.6: Average GC-composition by environment. The average values were
calculated from the GC-content of all pooled metagenomic sequences. Analysed
sequences were classified to one of the 10 phyla found to be most abundant across
all sampled biomes in an environmental category.
To determine if there was a correlative relationship between the GC-content of
each phyla, the Spearman correlation coefficients along with their significance were
calculated. Correlations were initially inspected for the binned mean GC-values for
each phylum (n=10) in every dataset (n=183) (Table 4.2A). The GC-contents of all
phyla were significantly correlated (p << 0.05) to those of other phyla, much more
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often than the 5% expected by chance. The GC-content of Deinococcus-Thermus
– was significantly correlated to that of other phyla in 56% of all cases. The GC-
contents of the remaining phyla were significantly correlated to those of the remaining
phyla 78%-100% of the time (Table 4.2A).
Many of the samples analyzed were extracted from a single type of environment
– the human gut. In order to examine whether environmental factors imposed vari-
ability in nucleotide content within a similar type of environment, the correlations
described above were recalculated using only the 111 human gut samples. Even when
looking only within a single type of environment, the GC-content of different phyla
correlated much more frequently than expected by chance (Table 4.2B). This was
least true for Deinococcus-Thermus – which had GC-content levels that correlated
significantly to only one other phylum. The Actinobacteria phylum showed significant
correlations to only three other phyla (33%). However, the remaining eight phyla had
GC-contents that were significantly correlated to those of other phyla in a minimum
of 67% of the cases.
Because the human gut samples constituted the majority of our datasets, gut
samples were removed from consideration to quantify the contribution of the other
environment types to observed correlations (Table 4.2C). Once gut samples were
removed, the percentage of correlations for all phyla that were significantly correlated
ranged between 67%-89% (Tables 4.2C, 4.5).
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Table 4.2: Phyla pair-wise Spearman correlation coefficients for A) All
Environments, B) Human Gut Environment, C) All Environments minus the
Human Gut. * Denotes significance. Legend: Act=Actinobacteria,
Bact=Bacteroidetes, Chl=Chlamydiae, Cren=Crenarchaeota,
DT=Deinococcus-Thermus, Eury=Euryarchaeota, Firm=Firmicutes,
Pro=Proteobacteria, Spiro=Spirochaetes, Ten=Tenericutes
A Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.169* -0.084 0.216* 0.661* 0.56* 0.032 0.56* -0.203* -0.213*
Bact 0.169* 1 0.544* 0.458* 0.161* 0.596* 0.758* 0.607* 0.661* 0.26*
Chl -0.084 0.544* 1 0.429* -0.108 0.325* 0.614* 0.235* 0.688* 0.457*
Cren 0.216* 0.458* 0.429* 1 0.121 0.683* 0.265* 0.296* 0.318* 0.259*
DT 0.661* 0.161* -0.108 0.121 1 0.304* 0.104 0.394* -0.13 -0.227*
Eury 0.56* 0.596* 0.325* 0.683* 0.304* 1 0.296* 0.621* 0.249* 0.137
Firm 0.032 0.758* 0.614* 0.265* 0.104 0.296* 1 0.477* 0.774* 0.366*
Pro 0.56* 0.607* 0.235* 0.296* 0.394* 0.621* 0.477* 1 0.245* -0.067
Spiro -0.203* 0.661* 0.688* 0.318* -0.13 0.249* 0.774* 0.245* 1 0.601*
Ten -0.213* 0.26* 0.457* 0.259* -0.227* 0.137 0.366* -0.067 0.601* 1
B Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.016 0.085 0.048 0.444* 0.248* 0.056 0.394* 0.075 0.063
Bact 0.016 1 0.575* 0.759* 0.022 0.716* 0.627* 0.51* 0.804* 0.347*
Chl 0.085 0.575* 1 0.637* -0.008 0.566* 0.555* 0.282* 0.725* 0.349*
Cren 0.048 0.759* 0.637* 1 -0.048 0.717* 0.559* 0.423* 0.779* 0.441*
DT 0.444* 0.022 -0.008 -0.048 1 -0.052 0.166 0.094 -0.023 -0.089
Eury 0.248* 0.716* 0.566* 0.717* -0.052 1 0.455* 0.528* 0.749* 0.497*
Firm 0.056 0.627* 0.555* 0.559* 0.166 0.455* 1 0.412* 0.779* 0.381*
Pro 0.394* 0.51* 0.282* 0.423* 0.094 0.528* 0.412* 1 0.489* 0.125
Spiro 0.075 0.804* 0.725* 0.779* -0.023 0.749* 0.779* 0.489* 1 0.49*
Ten 0.063 0.347* 0.349* 0.441* -0.089 0.497* 0.381* 0.125 0.49* 1
C Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.554* -0.015 -0.003 0.753* 0.792* 0.485* 0.803* 0.08 -0.266*
Bact 0.554* 1 0.431* 0.386* 0.368* 0.779* 0.908* 0.719* 0.557* 0.139
Chl -0.015 0.431* 1 0.636* -0.082 0.337* 0.525* 0.124 0.658* 0.558*
Cren -0.003 0.386* 0.636* 1 0.033 0.361* 0.422* 0.105 0.539* 0.478*
DT 0.753* 0.368* -0.082 0.033 1 0.524* 0.298* 0.584* 0.042 -0.233*
Eury 0.792* 0.779* 0.337* 0.361* 0.524* 1 0.699* 0.815* 0.412* 0.067
Firm 0.485* 0.908* 0.525* 0.422* 0.298* 0.699* 1 0.693* 0.587* 0.195
Pro 0.803* 0.719* 0.124 0.105 0.584* 0.815* 0.693* 1 0.183 -0.254*
Spiro 0.08 0.557* 0.658* 0.539* 0.042 0.412* 0.587* 0.183 1 0.664*
Ten -0.266* 0.139 0.558* 0.478* -0.233* 0.067 0.195 -0.254* 0.664* 1
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Figure 4.7: Phyla pair-wise Spearman correlation coefficients for all environments. *
denotes significance.
52
Figure 4.8: Phyla pair-wise Spearman correlation coefficients for human gut
environment. * denotes significance.
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Figure 4.9: Phyla pair-wise Spearman correlation coefficients for all non-human gut
environments. * denotes significance.
To ensure that the observed correlative effects were not caused by outliers, the
analysis was re-run in the same manner as before except that sequences were re-
moved if their GC-content value fell outside the interquartile region (IQR) for each
phylum (Table 4.3, Figure 4.10). Results remained consistent, in that for all phyla,
GC-contents significantly correlated with those of other phyla much more frequently
than expected by chance (Table 4.5). For analysis involving all samples, Tenericutes
had the lowest percentage of significant correlations at 22%. For all remaining phyla,
significant correlations were observed in between 55.6% - 88.9% of the cases (Ta-
ble 4.3A, Figure 4.10). When looking at correlations for only human gut datasets,
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Deinococcus-Thermus (11.1%), Actinobacteria (22.2%), and Tenericutes (22.2%) had
the lowest number of significant correlations. For the remaining phyla, significant
correlations were observed between 55.6% - 77.8% of cases (Table 4.3B, Figure 4.11).
Excluding the human gut datasets from the analysis, the GC-contents of all phyla
were significantly correlated between 55.5% to 100% of the time (Table 4.3C, Fig-
ure 4.12).
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Table 4.3: Spearman correlation coefficients using data filtered to include
within-interquartile region values for A) All Environments, B) Human Gut
Environment, C) All Environments minus the Human Gut. * Denotes significance.
Legend: Act=Actinobacteria, Bact=Bacteroidetes, Chl=Chlamydiae,
Cren=Crenarchaeota, DT=Deinococcus-Thermus, Eury=Euryarchaeota,
Firm=Firmicutes, Pro=Proteobacteria, Spiro=Spirochaetes, Ten=Tenericutes
A Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.315* -0.007 0.436* 0.605* 0.58* 0.115 0.517* -0.292* -0.026
Bact 0.315* 1 0.368* 0.5* 0.308* 0.723* 0.563* 0.576* 0.343* 0.197*
Chl -0.007 0.368* 1 0.218* 0.105 0.273* 0.302* 0.177* 0.392* 0.203*
Cren 0.436* 0.5* 0.218* 1 0.276* 0.724* 0.174* 0.331* -0.044 0.207*
DT 0.605* 0.308* 0.105 0.276* 1 0.385* 0.161* 0.333* -0.067 0.102
Eury 0.58* 0.723* 0.273* 0.724* 0.385* 1 0.271* 0.501* 0.055 0.169*
Firm 0.115 0.563* 0.302* 0.174* 0.161* 0.271* 1 0.632* 0.622* 0.114
Pro 0.517* 0.576* 0.177* 0.331* 0.333* 0.501* 0.632* 1 0.22* 0.057
Spiro -0.292* 0.343* 0.392* -0.044 -0.067 0.055 0.622* 0.22* 1 0.217*
Ten -0.026 0.197* 0.203* 0.207* 0.102 0.169* 0.114 0.057 0.217* 1
B Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 -0.064 -0.097 0.008 0.3* 0.029 -0.002 0.288* -0.054 0.032
Bact -0.064 1 0.287* 0.397* 0.093 0.693* 0.397* 0.316* 0.535* 0.178
Chl -0.097 0.287* 1 0.207* 0.013 0.252* 0.236* -0.01 0.414* 0.136
Cren 0.008 0.397* 0.207* 1 0.045 0.443* 0.32* 0.168 0.411* 0.276*
DT 0.3* 0.093 0.013 0.045 1 0.026 0.039 -0.158 -0.021 0.08
Eury 0.029 0.693* 0.252* 0.443* 0.026 1 0.304* 0.316* 0.587* 0.272*
Firm -0.002 0.397* 0.236* 0.32* 0.039 0.304* 1 0.547* 0.737* 0.079
Pro 0.288* 0.316* -0.01 0.168 -0.158 0.316* 0.547* 1 0.465* 0.008
Spiro -0.054 0.535* 0.414* 0.411* -0.021 0.587* 0.737* 0.465* 1 0.072
Ten 0.032 0.178 0.136 0.276* 0.08 0.272* 0.079 0.008 0.072 1
C Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.602* 0.02 0.113 0.707* 0.758* 0.491* 0.727* 0.086 -0.174
Bact 0.602* 1 0.33* 0.535* 0.444* 0.898* 0.829* 0.787* 0.518* 0.151
Chl 0.02 0.33* 1 0.296* 0.207 0.25* 0.356* 0.273* 0.509* 0.498*
Cren 0.113 0.535* 0.296* 1 0.19 0.482* 0.427* 0.343* 0.475* 0.195
DT 0.707* 0.444* 0.207 0.19 1 0.544* 0.308* 0.531* 0.173 0.103
Eury 0.758* 0.898* 0.25* 0.482* 0.544* 1 0.733* 0.81* 0.368* 0.099
Firm 0.491* 0.829* 0.356* 0.427* 0.308* 0.733* 1 0.813* 0.542* 0.068
Pro 0.727* 0.787* 0.273* 0.343* 0.531* 0.81* 0.813* 1 0.327* -0.036
Spiro 0.086 0.518* 0.509* 0.475* 0.173 0.368* 0.542* 0.327* 1 0.424*
Ten -0.174 0.151 0.498* 0.195 0.103 0.099 0.068 -0.036 0.424* 1
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Figure 4.10: Phyla pair-wise Spearman correlation coefficients for all environments
(IQR-filtered). * denotes significance.
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Figure 4.11: Phyla pair-wise Spearman correlation coefficients for human gut
environment (IQR-filtered). * denotes significance.
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Figure 4.12: Phyla pair-wise Spearman correlation coefficients for all non-human
gut environments (IQR-filtered). * denotes significance.
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Finally, to examine whether these results could be related to some artifact due
to amino acid usage, all sample sequences were annotated to identify protein-coding
sequences. This permitted the calculation of the GC-content in the 3rd-codon posi-
tions of fourfold degenerate codons. It also allowed an examination as to whether
these GC-contents were also correlated between phyla across environments. The 3rd
codon positions of fourfold degenerate codons do not affect the amino acid sequence
of a protein. Therefore, their nucleotide content should not be affected by selection
at the level of amino acid usage. Correlative analysis of the GC-content at the 3rd
codon position had similar results to those reported previously. In other words the
GC-content of 3rd codon positions of fourfold degenerate codons within protein-coding
genes is correlated between phyla across environments much more frequently than the
5% expected by chance (Table 4.4, Figure 4.13). When correlations were calculated
across all samples, the percentage of significant correlations ranged between 66.7%
and 88.9% for the different phyla examined (Table 4.4A). When only the human gut
datasets were considered, The GC-contents of Deinococcus-Thermus and Actinobac-
teria were significantly correlated to those of three (33.3%) and one (11.1%) other
phyla respectively. The GC-contents of the remaining phyla were found to be sig-
nificantly correlated to those of 66.7% and 88.9% of the other phyla (Table 4.4B,
Figure 4.14). Lastly, when excluding the human gut datasets, the GC-contents of
fourfold degenerate 3rd codon positions were significantly correlated for 55.5%-100%
of comparisons (Tables 4.4C, 4.5, Figure 4.15).
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Table 4.4: Spearman correlation coefficients using 3rd codon position data of 4-fold
redundant amino acids of for A) All Environments, B) Human Gut Environment,
C) All Environments minus the Human Gut. * Denotes significance. Legend:
Act=Actinobacteria, Bact=Bacteroidetes, Chl=Chlamydiae, Cren=Crenarchaeota,
DT=Deinococcus-Thermus, Eury=Euryarchaeota, Firm=Firmicutes,
Pro=Proteobacteria, Spiro=Spirochaetes, Ten=Tenericutes
A Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.49* 0.066 0.081 0.585* 0.583* 0.371* 0.678* 0.247* -0.041
Bact 0.49* 1 0.467* 0.408* 0.504* 0.606* 0.731* 0.697* 0.703* 0.088
Chl 0.066 0.467* 1 0.33* 0.102 0.201* 0.475* 0.18* 0.68* 0.236*
Cren 0.081 0.408* 0.33* 1 -0.065 0.545* 0.345* 0.243* 0.385* 0.332*
DT 0.585* 0.504* 0.102 -0.065 1 0.208* 0.52* 0.524* 0.335* -0.272*
Eury 0.583* 0.606* 0.201* 0.545* 0.208* 1 0.431* 0.608* 0.391* 0.158*
Firm 0.371* 0.731* 0.475* 0.345* 0.52* 0.431* 1 0.565* 0.724* 0.152*
Pro 0.678* 0.697* 0.18* 0.243* 0.524* 0.608* 0.565* 1 0.437* -0.018
Spiro 0.247* 0.703* 0.68* 0.385* 0.335* 0.391* 0.724* 0.437* 1 0.207*
Ten -0.041 0.088 0.236* 0.332* -0.272* 0.158* 0.152* -0.018 0.207* 1
B Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.237* 0.168 0.128 0.339* 0.361* 0.092 0.402* 0.221* 0.204*
Bact 0.237* 1 0.504* 0.637* 0.307* 0.544* 0.513* 0.513* 0.72* -0.094
Chl 0.168 0.504* 1 0.421* 0.042 0.392* 0.408* 0.042 0.624* -0.072
Cren 0.128 0.637* 0.421* 1 0.063 0.581* 0.501* 0.318* 0.688* 0.084
DT 0.339* 0.307* 0.042 0.063 1 -0.007 0.327* 0.219* 0.188* -0.088
Eury 0.361* 0.544* 0.392* 0.581* -0.007 1 0.356* 0.425* 0.681* 0.052
Firm 0.092 0.513* 0.408* 0.501* 0.327* 0.356* 1 0.293* 0.697* 0.063
Pro 0.402* 0.513* 0.042 0.318* 0.219* 0.425* 0.293* 1 0.462* 0.134
Spiro 0.221* 0.72* 0.624* 0.688* 0.188* 0.681* 0.697* 0.462* 1 0.032
Ten 0.204* -0.094 -0.072 0.084 -0.088 0.052 0.063 0.134 0.032 1
C Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1 0.684* -0.032 -0.023 0.894* 0.837* 0.64* 0.885* 0.416* -0.15
Bact 0.684* 1 0.325* 0.313* 0.65* 0.815* 0.91* 0.785* 0.726* 0.16
Chl -0.032 0.325* 1 0.489* 0.023 0.185 0.435* 0.144 0.613* 0.251*
Cren -0.023 0.313* 0.489* 1 0.087 0.326* 0.33* 0.138 0.39* 0.208
DT 0.894* 0.65* 0.023 0.087 1 0.752* 0.651* 0.848* 0.386* -0.224
Eury 0.837* 0.815* 0.185 0.326* 0.752* 1 0.756* 0.845* 0.598* 0.02
Firm 0.64* 0.91* 0.435* 0.33* 0.651* 0.756* 1 0.78* 0.785* 0.208
Pro 0.885* 0.785* 0.144 0.138 0.848* 0.845* 0.78* 1 0.547* -0.011
Spiro 0.416* 0.726* 0.613* 0.39* 0.386* 0.598* 0.785* 0.547* 1 0.286*
Ten -0.15 0.16 0.251* 0.208 -0.224 0.02 0.208 -0.011 0.286* 1
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Figure 4.13: Spearman correlation coefficients for 3rd codon position of four-fold
redundant amino acids in all environments. A * indicates significance.
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Figure 4.14: Spearman correlation coefficients for 3rd codon position of four-fold
redundant amino acids in human gut environment. A * indicates significance.
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Figure 4.15: Spearman correlation coefficients for 3rd codon position of four-fold
redundant amino acids in non-human gut environments. A * indicates significance.
64
Table 4.5: Number of significant Spearman correlations coefficients for All
Environments, Human Gut Environment, and All Environments minus the Human
Gut. For conditions, O=original data, IQR=Interquartile Region (all GC values
outside of IQR were excluded), and T=3rd Codon Position. Legend:
Act=Actinobacteria, Bact=Bacteroidetes, Chl=Chlamydiae, Cren=Crenarchaeota,
DT=Deinococcus-Thermus, Eury=Euryarchaeota, Firm=Firmicutes,
Pro=Proteobacteria, Spiro=Spirochaetes, Ten=Tenericutes
Groups All Human Gut Non-Human Gut
Conditions O IQR T O IQR T O IQR T
Act 7 6 6 3 2 6 6 5 6
Bact 9 9 8 7 6 8 8 8 8
Chl 7 7 7 7 5 5 6 7 5
Cren 8 8 7 7 6 6 6 6 5
DT 5 6 7 1 1 5 6 5 6
Eury 8 8 9 8 7 7 8 8 7
Firm 7 7 9 7 6 7 8 8 8
Pro 8 8 8 7 5 7 6 8 6
Spiro 8 6 9 7 6 8 6 7 9
Ten 7 5 6 6 2 1 6 2 2
Total 74 70 76 60 46 60 66 64 62
Combined, these results demonstrate that whether different environment types
were considered, or only one type of environment (the human gut) was considered,
the GC-contents of different phyla correlated across samples much more frequently
than would be expected by chance. These results remain consistent whether the
entire metagenomic sequence is used to calculate GC-content, or whether one used
only the four-fold degenerate 3rd codon positions of protein-coding sequences. These
results also remain consistent when GC-content outliers are removed from consid-
eration. Such results would only be expected if environmental differences between
samples influence the nucleotide content of each phylum in a correlated manner. It is
striking that such nucleotide content affecting environmental differences exist not only
between diverse environmental types, but also within a single type of environment.
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4.4.3 GC-content of fourfold degenerate amino acids
The correlations between phyla at the 3rd codon position of four-fold redundant
amino acids confirms the correlation results calculated for the non-annotated and
IQR-filtered data. It also provides a glimpse into the behavior of a position whose
nucleotide selection will not alter the produced amino acid. If guanine and cytosine
are not under selection – and we ignored the known AT-mutation bias, one would
expect to see that 50% of the positions would be G or C. If we consider the AT-
mutation bias, one would expect to see a greater percentage of A or T nucleotides.
However, many of the environments – especially those that were GC-rich, show a
disproportionate number of the four-fold redundant amino acids having increased
GC-levels in the 3rd codon position (Figure 4.16).2
Table 4.6: Table to illustrate the limited opportunities that exist for adenine and
thymine in the 1st and 2nd codon position of four-fold redundant amino acids (as
seen in Figure 4.16).
Amino Acids 1st Position 2nd Position
Alanine G C
Arginine C G
Glycine G G
Leucine C T
Proline C C
Serine T C
Threonine A C
Valine G T
Total 2 A-T, 6 G-C 2T, 6 G-C
2Note that only two of the eight four-fold redundant amino acids with have adenine or thymine
in the 1st and 2nd codon position (Table 4.6).
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Figure 4.16: Nucleotide GC counts by codon position and environment. *Nucleotide
is either A-T (0%) or G-C (100%).
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Figure 4.16 (continued)
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Figure 4.16 (continued)
4.4.4 Different environments do not differ by the genera they contain
The correlations in the GC-contents of different phylogenetic taxa across environ-
ments were performed at the phylum level. This was due to an imposed constraint –
namely, that it is not currently feasible to reliably classify metagenomic short reads
at lower levels of taxonomy. As such, it was not possible to examine whether GC-
contents of different genera or species were correlated across environments. While one
cannot reliably classify individual shotgun sequences at taxonomic levels much lower
than phylum with great confidence, the hope is that the classifications will be reli-
able enough to allow an examination of which genera are present within each sample
(without attempting to estimate their relative abundance). This should allow us to
at least examine whether genera tended to be excluded from environments entirely.
To measure environmental similarity, the relatively unreliable genus-level taxonomic
information was employed to examine how comparable the environments were in the
genera they contained. In this respect, no large differences between environments
were found. The largest observed difference occurred between the Fish Gut and the
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Coral environments – which contained 97.9% of the same genera (Table 4.7). All
remaining samples were at least 98% identical in the identity of the genera they con-
tained. These results imply that selection on nucleotide composition very rarely if at
all remove entire genera from the environment. It is greatly anticipated that this can
be more carefully verified in the near future, when sequencing will yield longer reads
which will improve the accuracy of the lower-taxonomic classifications.
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4.4.5 Human gut samples that are dominated by Actinobacteria tend to
be more GC-rich than other human gut samples
The mean GC variation found between highly dissimilar environments such as soil
and fresh pond water (Figure 4.6) can also be observed across all the samples in the
human gut environment (Figure 4.17). When examining the phylogenetic classifica-
tion of different human gut samples it became clear that these could be divided into
two groups: those that were dominated by Actinobacteria and those in which the most
prevalent phyla were Bacteroidetes, Firmicutes and Proteobacteria (Figure 4.18).
This led to the question of whether the gut samples dominated by Actinobacteria
(a high GC phylum) tended to differ in nucleotide composition from the other sam-
ples. To address this question, the human gut samples were ranked separately based
on their abundance of Actinobacteria and based on the GC-richness of each of the 10
examined phyla (11 lists in total). It was observed that 24 samples that were dom-
inated (at least 50% relative abundance) by Actinobacteria. These Actinobacteria-
dominated human gut samples tended to be significantly enriched for guanine and cy-
tosine (when compared to a hypergeometric distribution) in nine out of the 10 phyla
(Actinobacteria, Bacteroidetes, Chlamydiae, Crenarchaeota, Deinococcus-Thermus,
Euryarchaeota, Proteobacteria, Spirochaetes, and Tenericutes (Table 4.8A)). Even
the strongly AT-rich phyla tended to be more GC-rich within Actinobacteria domi-
nated guts than within other guts. A different statistical test was used to determine
if the GC-content of each phylum in the 24 (22%) Actinobacteria-dominated samples
was higher than the GC-content of the remaining 78% of the (non Actinobacteria-
dominated) samples. The average GC-content of each phylum was compared; within
the 22% of gut samples in which Actinobacteria were most abundant, to its average
GC-content in the remaining gut samples. This comparison showed that, with the ex-
ception of Firmicutes, Deinococcus-Thermus, and Tenericutes, the GC-content for all
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phyla was significantly higher within the Actinobacteria-rich gut samples, compared
to the gut samples that were less rich in Actinobacteria (p << 0.05, according to a
Mann-Whitney test, Table 4.8B). Together, these results suggest that environments
dominated by Actinobacteria tend to be those in which selection exists for higher
GC-content, across the majority of all phyla.
Figure 4.17: Mean GC-composition of each of the 111 samples collected from the
human gut environment. Each data point was created by calculating the mean
GC-content of all pooled individual sample reads.
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Table 4.8: Within the human gut, high abundance of the GC-rich phylum
Actinobacteria is associated with higher GC-contents of most other phyla. (A)
Hypergeometric Probability. There were 24 datasets (∼22%) from the human gut
that were dominated by Actinobacteria. The number in the table indicate how
many of the 24 datasets ordered by the GC-content of a phylum were found within
the top 24 datasets ordered by the relative abundance of Actinobacteria (the p-value
of the hypergeometric distribution is in parenthesis). (B) Mann-Whitney-Wilcoxon
p-values for each phylum comparing the mean GC-content for the top 22% guts
with the bottom 78% guts (when ordered by Actinobacteria abundance).
A # of top 24 most Actinobacteria-rich
samples that are most GC-rich
(hypergeometric p-values)
Actinobacteria (GC) 9 (0.026)
Bacteroidetes (GC) 10 (0.008)
Chlamydiae (GC) 11 (0.002)
Crenarchaeota (GC) 11 (0.002)
Deinococcus-Thermus (GC) 9 (0.026)
Euryarchaeota (GC) 16 (0)
Firmicutes (GC) 5 (0.220)
Proteobacteria (GC) 9 (0.026)
Spirochaetes (GC) 11 (0.002)
Tenericutes (GC) 10 (0.008)
B Mann-Whitney-Wilcoxon p-values
Actinobacteria 7.4e-6
Bacteroidetes 6.4e-4
Chlamydiae 2.4e-4
Crenarchaeota 1.6e-4
Deinococcus-Thermus 0.257
Euryarchaeota 1.8e-10
Firmicutes 0.198
Proteobacteria 3.0e-4
Spirochaetes 5.2e-4
Tenericutes 0.077
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4.5 Discussion
The results presented here demonstrate that both phylogeny and environment
contribute to the determination of prokaryotic nucleotide content.
The first finding is that different phyla are characterized by different mean GC-
contents and that some phyla are characterized by a much broader GC-content range
than others. These averages and possible ranges of nucleotide compositions are, to a
large extent, maintained across different environments. By examining the sequence
variation of fully-sequenced members of each phylum, it could be demonstrated that
even phyla with very low levels of nucleotide content variation were often highly vari-
able in their sequences. Thus, low levels of nucleotide content variation within certain
phyla could not be explained by low levels of sequence variation within these phyla.
A caveat must be added as the range of strains sequenced for each phylum might
be limited and because sequences were not selected at random for whole genome se-
quencing. It therefore becomes possible that strains exist of those phyla for which one
observed low levels of nucleotide content variation that have very different nucleotide
contents. However, the range of nucleotide contents observed for each phylum was
largely maintained both within fully-sequenced genomes and within metagenomic
sequences extracted from each of the diverse environments sampled. In order for
previously unknown members of a phylum to be outside the range of GC-contents
calculated for that phylum (from the metagenomic samples), it would require suffi-
cient divergence from the sequenced members of that phylum so as not to be assigned
to the same phylum. This seems less likely. At a minimum, it is demonstrated that
for all known members of certain phylum (and for all their relatives that are closely
enough related so as to be classified to these phyla from short metagenomic reads),
there are low levels of nucleotide content variation that cannot be explained by low
levels of sequence diversity. Phylogeny therefore seems to impose a clear limit on the
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range of nucleotide content a prokaryote can adopt.
At the same time, and perhaps even more interestingly, the results show that GC-
content varied across environments in a manner that is correlated across prokaryotic
phyla. This suggests that whatever force influenced the nucleotide composition of
one phylum influenced that of the other phyla. Therefore, variation in nucleotide
composition does not stem entirely from differences in phylogeny. Rather, it is prob-
able that the environment exerts some sort of pressure which acts upon all phyla to
influence the GC-content in a related manner. Environmentally shaped differences
in GC-content were apparent when radically different environments were considered
and when different samples extracted from a single type of environment (the human
gut) were examined. It would therefore appear that the environmental factors which
shape nucleotide content vary not only among largely different environments (e.g.,
soil vs. water vs. human gut), but also within a single type of environment.
It is not yet known what attributes are responsible for determining the range
of GC-compositions of the different phyla. It is unlikely that members of a given
phylum face consistent selection to maintain similar nucleotide composition ranges
across all environments. Therefore, it appears more likely that the average and range
of nucleotide compositions adoptable by members of a given phylum would be de-
termined by neutral processes. It has long been assumed that different phyla would
have different nucleotide compositions due to differences in mutational biases. How-
ever, more recently it was demonstrated that even in GC-rich prokaryotes, mutation
is universally AT-biased [58, 59]. Mutation is however, not the only neutral process
that could explain differences in prokaryotic nucleotide composition. It is possible
that different phyla encode, or in some cases, do not encode the various mechanisms
that allow them to modulate nucleotide content in the face of AT-biased mutation.
For example, as described in the introduction, it has been demonstrated that gene
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conversion is GC-biased in many eukaryotes – including humans and other mammals
[36]. Additionally, some evidence exists for similar BGC occurring in E. coli [125].
Such a BGC mechanism may exist in some but not all prokaryotic phyla, and may be
more or less GC-biased in different phyla. Furthermore, different phyla may experi-
ence lower or higher recombination rates. Such differences between phyla may lead to
differences in their range of possible GC-compositions. However, much more research
is necessary to determine why phyla vary so greatly in their nucleotide composition.
This study provides evidence for environmental effects on nucleotide composition.
However, we still do not know which environmental factors affect GC-content. Past
studies have attempted to link different environmental factors to the nucleotide com-
position of microbes. One of the most obvious factors thought to influence GC-content
was selection on genome stability exerted by high temperatures. Prokaryotes living in
high temperatures may need to maintain higher GC-levels, because these may provide
better genome stability when temperatures are elevated. Yet, the environmentally-
influenced differences we observe between nucleotide content within the human gut
clearly cannot be explained by differences in temperature. After all, different hu-
man guts are not expected to vary greatly when it comes to temperature. It also
seems unlikely that any other simple environmental factor, such as differences in pH,
or salinity would entirely explain the observed environmentally-driven variation in
nucleotide content.
The results demonstrate that selection exerted by the environment likely influences
nucleotide composition. This suggests that nucleotide content is a selected trait. The
observation that variation in GC-content among different human gut samples is envi-
ronmentally influenced raises the subject of evolutionary time. Nucleotide content is
a relatively slowly evolving trait, and ultimately, a large number of mutations would
be required to significantly alter GC-composition. If within a certain environment
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there is selection on prokaryotes to be more GC-rich than in other environments,
will prokaryotes have time to evolve towards that GC-content when they are already
inside the environment? A second possibility is that selection acts at the moment of
introduction into an environment. A specific prokaryote with a nucleotide composi-
tion that clashes greatly with the optimal level of a given environment, may not be
able to colonize that environment in the first place. If this is indeed the case, we
would expect to see that certain species of prokaryotes may be excluded from certain
environments due to their mismatched nucleotide composition. However, considering
that a microbial community consists of phyla with very distinct ranges of GC-levels
appearing within the same environment, it seems likely that survival is not so much
the question as it is about evolution and community coorporation.3 On a related note,
it is not currently possible to reliably characterize the phylogeny of short metagenomic
reads to the species level. However, when it was investigated whether different envi-
ronments varied greatly in their genera, no large differences were found. Therefore, it
appears that entire genera are not categorically excluded from environments based on
nucleotide composition. However, it is not possible to currently estimate the extent
to which the relative abundance of different genera is influenced by selection at the
level of nucleotide composition. Advances in sequencing technology should soon allow
for longer read lengths. This in turn should make it possible to more reliably clas-
sify phylogeny within metagenomes down to the genera and even species-level. Once
this occurs, we should be able to examine possible fluctuations in the abundance of
different genera and how these relate to nucleotide composition. We will also be able
to investigate whether certain species are excluded from environments due to their
nucleotide composition.
Within human guts, significant differences in nucleotide composition were ob-
3As an example of this, Tenericutes is a low GC-phylum and is present in samples with
Deinococcus-Thermus – a high GC phylum.
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served between those guts that were dominated by Actinobacteria, and those guts that
were dominated by Firmicutes, Bacteroidetes and Proteobacteria. In Actinobacteria-
dominated gut samples, other phyla – even those that were AT-rich, tended to be
relatively more GC-rich than those in the remaining gut samples. This trend could
be explained in two ways. First, it is possible that the high abundance of Actinobac-
teria itself selects for the GC-richness of other phyla. Second, it is possible that both
the higher abundance of Actinobacteria and the elevated GC-content of the other
phyla are the result of some characteristic of these guts. For example, it is possi-
ble that the environmental factor or factors that select for GC-richness increases the
abundance of Actinobacteria (because they are highly GC-rich in general), and skews
the remaining, less-abundant phyla to be more GC-rich. If the latter scenario is cor-
rect, it implies that selection on nucleotide composition may be a factor affecting
prokaryotic phylogenetic composition within certain environments.
To conclude, the results demonstrate that while phylogeny is associated with a
specific prokaryotic nucleotide composition, the environment strongly influences that
composition. Combined, phylogeny and environment direct the GC-content seen in
an environment. Phylogeny appears to set the limits by which a given taxa may alter
its nucleotide composition. Different phyla are more or less flexible with regards to
the amounts of change in nucleotide composition they can accommodate. Within the
range possible for a certain phyla, environment seems to determine whether their GC-
content will be higher or lower. Both sharp differences in environment type (e.g., soil
vs. aquatic vs. human microbiome) as well as more subtle environmental differences
(as those observed between different human guts) significantly influence nucleotide
content. Thus, the environmental factors affecting nucleotide composition vary not
only between highly different environments, but also between more similar ones.
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5. Investigating Environmental Factors
5.1 Introduction
In the introduction of Chapter 4, there was a brief discussion of studies that have
attempted to link GC-content to environmental factors (e.g., temperature and aer-
obiosis). As mentioned previously, there is still much debate as to the strength of
their relationship to the GC-content of prokaryotes. The work and results of the
previous chapter indicate that both phylogeny and environment affect prokaryotic
GC-content. However, it does not address what environmental factors could influence
the nucleotide composition. This chapter strives to correlate the sample-affiliated
metadata with the GC-content of the same samples. Additionally, the influence of
viruses on prokaryotic GC-content is also investigated using clustered regularly inter-
spaced short palindromic repeats (CRISPRs) and viral metagenomic samples.
This chapter discusses the human gut samples (n=111) and 27 of the datasets
listed in the previous chapter (coral, fish slime, microbialites, water marine, water
pond fresh, and water pond saline). For the sake of brevity, these datasets will be
collectively referred to as "water" samples for the remainder of this chapter. This
chapter also introduces a new dataset comprised of 47 soil samples obtained from
Merlot vineyards in New York.
5.2 The Dance-off: Prokaryotes and Phages
Bacteriophages are viruses with which infect bacteria and archaea. Estimates have
suggested that bacteriophages surpass the number of prokaryotes at a ratio of ten to
one [43, 67]. Phages attempting to infect prokaryotic cells are presented with a host
of antiviral machinations which resist viral entry into the cell. However, one item
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that must be appreciated is that not all phages will infect every prokaryotic species
type [64]. Because phages are met with an enormous array of variation in prokaryotic
cellular membranes/walls, if for one reason or another, a phage can infect a panoply
of hosts, there may be a fitness cost to the myriad of adaptions that must take place
for this to occur. This could decrease the effectiveness of the infections and possibly
reduce to perpetuity of the virus.
An initial step in the infection process is that the phage must identify and dis-
tinguish the many host-specific cellular components [67]. As a means of survival,
prokaryotes have developed a series of mechanisms which prevent infection by phages
(or halt their replication cycle). Employed methods include modification of cell sur-
face receptors, surface protein production to mask surface receptors, and exopolysac-
charide (EPS) production to prevent adhesion to receptors by the bacteriophage.
However, this evolution (prokaryote mechanisms to resist bacteriophage infection) is
not one-sided. Phages have countered these advancements by employing tactics to
evade, deceive, and undermine these infection resistance mechanisms [67]. Some of
the counter mechanisms include recognizing numerous/modified prokaryotic recep-
tors and the production of lyase polysaccharides that cleave EPS [30, 67]. In the
event that the virus successfully invades the cell, prokaryotes have developed many
incredibly intricate methods including, but not limited to, the prevention of foreign
DNA translation (histone-like structuring proteins (H-NS)) and the adaptive immune
system incorporating CRISPRs.
Histone-like nucleotide structuring proteins (H-NS)
Histone-like nucleotide structuring proteins (H-NS) are one in a series of bacterial
proteins which contribute to the arrangement of their nucleoid structure and have
also been implicated in controlling DNA transcription [23, 34, 35, 61, 87, 90]. Briefly,
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these proteins bind to nucleic acids (generally curved) both upstream and downstream
of the promotor region thus trapping RNA polymerase and preventing transcription
(Figure 5.1). Research has shown that the H-NS proteins bind to regions of DNA that
are at a lower GC-level than that of the remaining genome – subverting the expression
of the AT-rich regions [61, 87, 89, 90]. Generally DNA that is derived from horizontal
gene transfer, plasmids, and phages have a lower GC-content than their prokaryotic
host [89]. If bacteria can indeed use H-NS as a means to distinguish between self
and non-self DNA (based on GC-content), it is possible that in an attempt to avoid
detection, viruses increase their GC-content. In response to this increase, bacteria
also increase their GC-content in order to maintain a distinctive barrier between itself
and foreignly acquired DNA. While these binding proteins are present only in gram
negative bacteria and have been studied specifically in Salmonella enterica serovar
Typhimurium (S. typhimurium), it is possible that all bacteria and archaea contain
different proteins that perform a similar binding function [23, 34, 87, 90].
CRISPRs
Methods utilized by prokaryotes to prevent infection can be thought of as being
part of the organism’s innate immune system [110]. Conversely, CRISPRs are part
of the organism’s adaptive immune system [8, 43, 135]. A CRISPR locus contains a
series of a carefully conserved short palindromic repeats (prokaryotic DNA) followed
by a spacer (foreign DNA) that are preceded by a leader sequence of approximately
20 – 500 AT-rich nucleotides [30, 48, 135]. CRISPR-associated (cas genes can be
located upstream or downstream of the CRISPR loci or somewhere else within the
prokaryotic genome – Figure 5.2) [30, 135]. The CRISPR locus is akin to a memory
cell and the cas proteins act in a catalytic manner [135]. Each palindromic repeat
and spacer is ∼21 – 48 and ∼26 – 72 nucleotides in length respectively [8, 30, 135].
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Figure 5.1: Depiction of H-NS function. A) Section of curved DNA (including
promoter region). B) Same DNA with added RNA polymerase. C) DNA, RNA
polymerase, and attached H-NS proteins which traps the RNA polymerase and
prevents transcription. (Image inspired by C. Dorman [34])
The number of cas genes varies between 4 – 20 nucleotides [8, 30]. Generally there
are less than 50 repeats in a CRISPR (though there have been reports of species with
much higher incidents), while the number of CRISPRs per organism varies greatly –
even between strains of a particular phylum [30].
Although current research describes several types of CRISPR-cas systems, all vari-
ants appear to adhere to the following phases – adaptive, expression, and interference
[30, 48, 135]. During the adaptive phase, the CRISPR array is expanded by the addi-
tion of foreign DNA (spacers) after the leader sequence as well as the duplication of
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Figure 5.2: CRISPR loci made up of a CRISPR-associated cas genes, a leader
sequence, and a series of repeats and spacers.
the palindromic repeats. During the expression or biogenesis phase, CRISPR loci are
transcribed and processed into small CRISPR RNAs (crRNAs). During the interfer-
ence stage, the crRNAs act as guides for the cas proteins which recognize and bind
to foreign DNA to halt the infection process [30, 43, 48, 135]. In recent years, the
CRISPR-cas system has been studied for many purposes – the current interest in the
system is to view a CRISPR loci as a historical document of bacteriophage infection.
5.3 Materials and Methods
5.3.1 Data sources
Shotgun-sequenced samples from 27 various water environments, 111 human guts,
and the soil from 47 New York Merlot vineyards were used to investigate potential
influential environmental factors. The environmental water samples and the human
gut samples were described previously (Chapter 4 [105]). For the Merlot vineyard
soil samples, the methods used to download datasets, filter reads, classify the se-
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quences, and the selection and filtering of sequences were identical to those employed
and discussed in Chapter 4 (see section 4.3.1 along with the top and bottom image
of Figure 4.1) [105]. As with the previous methodology, 10 phyla (Euryarchaeota,
Crenarchaeota, Actinobacteria, Bacteroidetes, Chlamydiae, Deinococcus-Thermus,
Firmicutes, Proteobacteria, Spirochaetes, and Tenericutes) were again selected for
analysis. For the biomes originating from the "water" environments, the investigators
performed an additional filtration step to collect viruses (bacteriophages) [32, 33, 107].
Hence, all of the "water" samples have a paired viral sample.
Taxonomic analysis and GC-content assessment were performed on over 26 million
prokaryotic sequences from 185 shotgun-sequenced metagenomic datasets. These
datasets were obtained from environmental samples from the human gut, "water",
and Merlot vineyard soil. Demographics for the prokaryotic water environments,
human gut, and the Merlot samples can be found in Table 5.1. Demographics for the
viral water environments samples can be found in Table 5.2.
Table 5.1: Number of prokaryotic datasets and sequences by environment. *Number
of classified sequences
Environment Number of Datasets Number of Sequences*
Coral 6 226,127
Fish Slime 2 73,697
Microbialites 3 370,085
Water Marine 5 591,963
Water PondFresh 4 294,704
Water PondSaline 7 253,194
Merlot Vineyard Soil 47 8,716,020
Human Gut 111 16,047,825
Total 185 26,278,911
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Table 5.2: Number of viral datasets and sequences by environment.
Environment Number of Datasets Number of Sequences
Coral 6 209,469
Fish Slime 2 109,788
Microbialites 3 418,248
Water Marine 5 1,023,344
Water PondFresh 4 397,755
Water PondSaline 7 532,846
Total 27 2,691,450
5.3.2 Assessing Environmental Influence Using Sample Metadata
The Merlot vineyard soil, "water", and human gut samples were used to assess
whether recorded environmental values (metadata) were correlated to the GC-content
of the prokaryotes identified in the metagenomic samples. Measured factors for the
Merlot soil samples included pH, temperature, moisture percentage, as well as the
percentage of carbon and nitrogen contained within each sample. For the "water"
samples, temperature, pH, and salinity measurements were utilized. For the human
gut samples, the country of origin and age of each sample donor were recorded. To
determine if any of the metadata for the samples were correlated to the sample mean
GC, Spearman correlation coefficients (with significance) were calculated.
Additionally, the correlative relationship between the GC-content of each phylum
(pair-wise comparisons) within the Merlot soil samples and within the "water" samples
was assessed using identical methods illustrated previously in Chapter 4 [105].1
Lastly, the possibility of bacteriophages acting as an influencer of prokaryotic GC-
content is examined. Two methods were employed to ascertain whether a relationship
1The human gut datasets have already been analyzed in Table 4.2 and Figure 4.8.
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could be established between prokaryotic GC-content and GC-content of the bacte-
riophages. The first method utilized Crass – a program which scans metagenomic
sequences for CRISPRs [119]. The success of finding a CRISPR increases with the
length of the sequences. Since the read lengths of next generation sequencing have
increased over time, it is more likely that the number of identified CRISPRs from
metagenomic samples sequenced at a later date, would be higher than metagenomic
samples sequenced at an earlier date. In other words, one would expect to find a
greater number of CRISPRs in the samples from the Merlot vineyard soil that were
collected circa 2012 than from the "water" samples that were collected from as early as
2005. The last method used to determine if bacteriophages could influence prokaryotic
GC-content involved the paired metagenomic viral (bacteriophages) samples. Finally,
correlations between the GC-levels of the prokaryotic samples and the GC-levels of
the accompanying viral samples were assessed along with employed statistical tests
used to measure relationships.
5.4 Results
5.4.1 GC-content of Samples
As formerly noted, this chapter uses four datasets in the analysis: Prokaryotic
samples from Merlot vineyard soil, prokaryotic samples from the human gut, prokary-
otic samples from "water" environments, and viral samples collected from the same
"water" environments at the same time and location as the prokaryotic "water" sam-
ples.
A phylogenetic tree based on species from the selected prokaryotic phyla and which
demonstrates the relationship from one phylum to another can be seen in Figure 5.3
[70, 118].
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Figure 5.3: Phylogenetic tree comprised of species from the phyla used in our
analysis. Color (inner circle) legend: Pink = Eukaryotes, Green = Archaea, Light
Violet = Bacteria.
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Human Gut Samples: Mean GC-content and pair-wise prokaryotic phylum Spearman
coefficients
Graphical representations of the mean GC-content of the human gut samples can
be found in Figure 4.17. Boxplots showing the GC-content of each phylum within
the human gut samples can be found in Figure 4.3. Spearman correlation coefficients
(with significance) for the human gut samples were performed previously in Chapter 4
(Table 4.2, Figure 4.8).
Merlot Vineyard Soil: Mean GC-content and pair-wise phylum Spearman coefficients
The mean GC-content of the Merlot samples varied from ∼57.5% to ∼61% (Fig-
ures 5.4 and 5.5). Similar to what was previously shown, the GC-content of all phyla
within the Merlot soil samples showed the GC-rich phyla to be Actinobacteria: 64.8%,
Deinococcus-Thermus: 63.6%, and Proteobacteria: 60.1%. The GC-intermediate
phyla were Bacteroidetes: 50.9%, Crenarchaeota: 51.9%, Euryarchaeota: 56.2%,
while the GC-poor phyla were Chlamydiae: 41.6%, Firmicutes: 47.1%, Spirochaetes:
46.5%, and Tenericutes: 35.0%. Additionally, the GC composition of the phyla within
the metagenomic datasets coincided with those of the referential fully-sequenced
genomes of the same phyla (Figure 4.4).
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Figure 5.4: Mean GC-composition of each of the 47 samples derived from the
Merlot vineyard soil environment. Each data point was created by calculating the
mean GC-content of all pooled individual sample reads.
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Figure 5.5: GC levels by phylum for all sequences within the Merlot vineyard soil
samples. Values originate from the calculated GC-content of all individual reads
(classified to a specific phylum) from the samples obtained from the 47 Merlot
vineyard soil samples.
To exclude the possibility that variation in GC-composition (between samples)
could be explained entirely by differences in phylogenetic composition, pairwise (phyla)
correlations were examined. Significant correlations would indicate that whatever
force influenced the nucleotide content in one phylum also had an effect on the nu-
cleotide content of the remaining phyla. Spearman correlations for the binned mean
GC-values for each phylum (n=10) in the Merlot datasets (n=47) were calculated
(Table 5.3). With the exception of Tenericutes, the GC-contents of all phyla were
significantly correlated (p << 0.05) to those of the remaining phyla, much more often
than the 5% expected by chance.
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Table 5.3: Phyla pair-wise Spearman correlation coefficients for Merlot vineyard soil
samples. * Denotes significance. Legend: Act=Actinobacteria, Bact=Bacteroidetes,
Chl=Chlamydiae, Cren=Crenarchaeota, DT=Deinococcus-Thermus,
Eury=Euryarchaeota, Firm=Firmicutes, Pro=Proteobacteria, Spiro=Spirochaetes,
Ten=Tenericutes
Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act NA -0.517* -0.480* -0.254 0.908* 0.386* -0.451* 0.803* 0.084 -0.040
Bact -0.517* NA 0.761* 0.765* -0.480* 0.309* 0.863* -0.416* 0.527* 0.015
Chl -0.480* 0.761* NA 0.709* -0.527* 0.179 0.815* -0.416* 0.617* 0.165
Cren -0.254 0.765* 0.709* NA -0.310* 0.626* 0.886* -0.008 0.695* -0.006
DT 0.908* -0.480* -0.527* -0.310* NA 0.297* -0.470* 0.738* 0.046 -0.130
Eury 0.386* 0.309* 0.179 0.626* 0.297* NA 0.478* 0.604* 0.537* -0.139
Firm -0.451* 0.863* 0.815* 0.886* -0.470* 0.478* NA -0.199 0.646* 0.036
Pro 0.803* -0.416* -0.416* -0.008 0.738* 0.604* -0.199 NA 0.072 -0.093
Spiro 0.084 0.527* 0.617* 0.695* 0.046 0.537* 0.646* 0.072 NA 0.032
Ten -0.040 0.015 0.165 -0.006 -0.130 -0.139 0.036 -0.093 0.032 NA
"Water" (Prokaryotes): Mean GC-content and pair-wise prokaryotic phylum Spear-
man coefficients
The mean GC-content of the prokaryotic "water" samples varied from ∼40.8%
to ∼62.4% (Figures 5.6 and 5.7). Similar to what was previously shown, the GC-
content of all phyla within the prokaryotic "water" environmental samples showed
the GC-rich phyla to be Actinobacteria: 62.9% and Deinococcus-Thermus: 63.6%.
The GC-intermediate phyla were Crenarchaeota: 50.5%, Euryarchaeota: 51.6%, and
Proteobacteria: 50.5%, while the GC-poor phyla were Bacteroidetes: 44.0%, Chlamy-
diae: 39.4%, Firmicutes: 39.9%, Spirochaetes: 37.2%, and Tenericutes: 30.6%. Addi-
tionally, the GC composition of the phyla within the metagenomic datasets coincided
with those of the referential fully-sequenced genomes of the same phyla (Figure 4.4).
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Figure 5.6: Mean GC-composition of each of the 27 prokaryotic "water" samples
colored by their specific environment. The average values were calculated from the
GC-content of all pooled metagenomic sequences in a sample.
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Figure 5.7: Pooled GC-levels by phylum for the prokaryotic "water" environmental
samples. Values originate from the calculated GC-content of all individual reads
(classified to a specific phylum) from the samples obtained from the 27
environmental "water" samples.
To exclude the possibility that variation in GC-composition (between samples)
could be explained entirely by differences in phylogenetic composition, pairwise (phyla)
correlations were examined. Significant correlations would indicate that whatever
force influenced the nucleotide content in one phylum also had an effect on the nu-
cleotide content of the significantly correlated phylum. Spearman correlations for the
binned mean GC-values for each phylum (n=10) in the prokaryotic "water" datasets
(n=27) were calculated (Table 5.4). The GC-contents of all phyla were significantly
correlated (p << 0.05) to those of other phyla, much more often than the 5% expected
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by chance.
Table 5.4: Phyla pair-wise Spearman correlation coefficients for prokaryotic "water"
environmental samples. * Denotes significance. Legend: Act=Actinobacteria,
Bact=Bacteroidetes, Chl=Chlamydiae, Cren=Crenarchaeota,
DT=Deinococcus-Thermus, Eury=Euryarchaeota, Firm=Firmicutes,
Pro=Proteobacteria, Spiro=Spirochaetes, Ten=Tenericutes
Act Bact Chl Cren DT Eury Firm Pro Spiro Ten
Act 1.000 0.413* 0.120 0.23 0.722* 0.714* 0.403* 0.761* 0.017 -0.176
Bact 0.413* 1.000 0.655* 0.797* 0.126 0.813* 0.955* 0.708* 0.639* 0.366
Chl 0.120 0.655* 1.000 0.637* -0.108 0.493* 0.653* 0.344 0.359 0.32
Cren 0.23 0.797* 0.637* 1.000 -0.024 0.693* 0.866* 0.532* 0.481* 0.215
DT 0.722* 0.126 -0.108 -0.024 1.000 0.382* 0.083 0.439* -0.031 -0.187
Eury 0.714* 0.813* 0.493* 0.693* 0.382* 1.000 0.821* 0.793* 0.371 0.187
Firm 0.403* 0.955* 0.653* 0.866* 0.083 0.821* 1.000 0.741* 0.575* 0.307
Pro 0.761* 0.708* 0.344 0.532* 0.439* 0.793* 0.741* 1.000 0.160 -0.165
Spiro 0.017 0.639* 0.359 0.481* -0.031 0.371 0.575* 0.160 1.000 0.697*
Ten -0.176 0.366 0.32 0.215 -0.187 0.187 0.307 -0.165 0.697* 1.000
"Water" (Viral): Mean GC-content
The mean GC-content of the viral "water" samples varied from ∼34.4% to ∼53.7%
(Figures 5.8). As classification of the bacteriophages was not performed, no box-plot
or correlative analysis of the viral samples is available.
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Figure 5.8: Mean GC-composition of each of the 27 viral "water" samples colored by
their specific environment. The average values were calculated from the GC-content
of all pooled metagenomic sequences in a sample.
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5.4.2 Environmental Factors: Correlating GC-content and Metadata
Metadata values acquired at sampling time in conjunction with the prokaryotic
mean GC-content were used to calculate the Spearman correlation coefficient.
Human Gut: Correlating environmental factors
The recorded metadata for the human gut samples included the age and geographic
location of the sample donor. Figure 5.9 shows a plot of the mean GC versus the age
of the sample donor (colored by donor’s country of origin).
Figure 5.9: The mean GC-content vs. the donor age of 111 human gut samples.
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Table 5.5: Spearman correlation coefficients between A: the donor’s age and the
sample mean GC. The analysis covers all human gut sample donors before being
subdivided into donors into their country of origin (Malawi, The United States of
America, and Venezuela). B: Spearman correlation coefficient for mean GC-content
and country of origin. Note: A numerical value was assigned to each country.
A Spearman Correlation Coefficient
All Donors -0.442 (1.322e-06)
Malawian Donors -0.762 (2.381e-05)
U.S.A. Donors -0.359 (0.003)
Venezuelian Donors -0.581 (0.006)
B Spearman Correlation Coefficient
All Donors 0.295 (0.0018)
When viewed collectively, the age of the donor and GC-content of the sample was
negatively and significantly correlated with a Spearman coefficient of -0.442. When
the samples were segregated according to country of origin, the Spearman coefficients
were -0.359, -0.762, and -0.581 respectively for samples originating from Malawi,
U.S.A., and Venezuela.
Merlot Vineyard Soil: Correlating environmental factors
No discernible trends were present when plotting the mean GC-content of each
Merlot soil sample colored by factors carbon/nitrogen ratio, percent of moisture in
soil sample, pH, soil type, temperature, or vineyard (Figure 5.10).
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Figure 5.10: The mean GC of the Merlot samples colored by specific factors
(carbonnitrogen ratio, moisture percentage, pH, soil type, temperature, and
vineyard). *Dark grey coloring signifies missing value.
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Table 5.6: Spearman correlation coefficients between measured factors and the
sample mean GC as well as between measured factors and the mean GC of every
phylum in the Merlot datasets. The only significant correlation was for the
temperature factor and the phylum Tenericutes.
Carbon Nitrogen Moisture Temp C.N pH
Sample MeanGC -0.101 0.149 0.099 -0.122 -0.098 0.036
Actinobacteria 0.075 0.041 0.106 0.317 0.088 0.072
Bacteroidetes -0.279 -0.24 -0.013 -0.07 -0.172 0.044
Chlamydiae -0.241 -0.202 0.022 0.017 -0.209 -0.085
Crenarchaeota -0.229 -0.215 0.134 -0.005 -0.159 0.032
Deinococcus-Thermus 0.075 0.031 0.004 0.358 0.123 0.116
Euryarchaeota -0.057 -0.06 0.075 0.166 -0.06 0.176
Firmicutes -0.317 -0.25 -0.043 0.092 -0.296 -0.068
Proteobacteria -0.042 -0.059 0.062 0.079 -0.008 0.039
Spirochaetes -0.17 -0.152 0.119 0.373 -0.047 0.055
Tenericutes 0.124 0.234 0.041 -0.505* -0.03 -0.022
Additionally, Spearman correlations between the mean GC-content of the Merlot
datasets to the metadata variables did not yield significant results (Table 5.6). In a
final attempt to investigate correlative effects, the Spearman coefficients between each
factor and the mean GC-content of the 10 phyla were calculated. In this final analysis,
the only significant coefficient occurred between Tenericutes and temperature (p-value
= 0.021) (Table 5.6).
"Water": Correlating environmental factors
Much of the metadata associated with the marine samples were not available. Of
the three recorded measurements (pH, salinity, and temperature), pH was available for
6 samples, salinity levels were available for 12 samples, and temperature was available
for 5 samples (Table 5.7). The salinity values were described as low, medium and high
and corresponded to the following ranges: 6-8% (low), 12-14% (medium), and 27-30%
(high). As the exact percentage of saline was not known for the samples, the average
value was calculated and used in the correlation assessment (Table 5.8). Despite
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this averaging, there was a strong correlation (p-value = 3.462e-05) between GC-
content and the level of salinity. Correlations for temperature and pH were deemed
unnecessary due to the low number of observations and the neigh-absent variation in
values.
Table 5.7: Recorded metatdata values for marine samples.
Environment Group MeanGC Temp Salinity pH
Coral TempPorCompHaw 42.316 30 NA 8.1
Coral pHPorCompHaw 43.008 20 NA 6.7
Coral NutPorCompHaw 43.353 20 NA 8.1
Coral DOCPorCompHaw 44.768 20 NA 8.1
Coral ConPorCompHaw 44.881 20 NA 8.1
Coral T0PortComHaw 46.286 20 NA 8.1
Fish_Slime FishMorSlimKentST 51.525 NA NA NA
Fish_Slime FishHealSlimKentST 53.159 NA NA NA
Microbialites HBCStromBahamas 48.283 NA NA NA
Microbialites PAStromBahamas 49.742 NA NA NA
Water_Marine PalmLI 44.537 NA NA NA
Water_Marine XmasLI 46.861 NA NA NA
Water_Marine KingLI 47.670 NA NA NA
Water_Marine FannLI 48.086 NA NA NA
Water_Marine SaltonSea1 50.621 NA NA NA
Water_PondSaline LowSalternSDbay 40.844 NA 7.0 NA
Water_PondSaline LowSalternSDbay 53.415 NA 7.0 NA
Water_PondSaline LowSalternSDbay 55.4 NA 7.0 NA
Water_PondSaline MedSalternSDbay 56.261 NA 13.0 NA
Water_PondSaline MedSalternSDbay 61.777 NA 13.0 NA
Water_PondSaline MedSalternSDbay 62.128 NA 13.0 NA
Water_PondSaline MedSalternSDbay 55.3 NA 13.0 NA
Water_PondSaline HighSalternSDbay 62.437 NA 28.5 NA
Water_PondSaline HighSalternSDbay 64.019 NA 28.5 NA
Water_PondSaline HighSalternSDbay 64.384 NA 28.5 NA
Water_PondSaline HighSalternSDbay 64.662 NA 28.5 NA
Water_PondSaline HighSalternSDbay 64.729 NA 28.5 NA
Table 5.8: Spearman correlation coefficients for "water" samples. Twelve samples
were associated with salinity values, and 6 samples were associated with the pH
values.
Factor Spearman Coefficient p-value
Salinity 0.913 3.462e-05
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5.4.3 Bacteriophages and GC-content
CRISPRs and GC-content of Merlot soil samples
Attempts were made to locate CRISPRs in the Merlot soil samples. There were
a small number of unique CRISPRs found in the samples (Table 5.9). However, the
reads were of insufficient length to identify multiple spacers (within a locus). This
meant that assessing the nucleotide composition of successive spaces as a means to
measure GC variations from a historical standpoint was not possible. Additionally,
the number of CRISPR spacers found within a single sample did not appear with a
frequency that would provide sufficient power for statistical significance.2
Table 5.9: CRISPRs identified in the Merlot soil samples.
CRISPR GC Sample MeanGC Spacer Length
28.57 58.35 43
77.42 59.65 32
68.57 57.53 36
70.97 58.93 32
57.14 60.0 43
65.79 58.43 39
64.86 58.5 38
55.26 59.23 39
62.16 58.92 38
53.85 59.92 40
67.74 59.92 32
36.67 58.33 31
2CRISPR information for the "water" samples and the human gut samples are not provided. The
length of these sequences were shorter than the Merlot sequences – most likely as a result of the
sequencing occurring at a later date. The number of identified CRISPRs in the "water" and human
gut samples were less than those identified in the Merlot vineyard soil samples.
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5.4.4 Relationship between viral and prokaryotic samples from marine
environment
Graphs showing the mean GC-content in the prokaryotic and viral samples that
were obtained from the "water" samples can be seen in Figures 5.11 and 5.12.
Figure 5.11: The mean GC-content of the prokaryotic water samples. Each data
point represents the mean GC-content of all pooled sequences within the specific
environmental sample.
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Figure 5.12: The mean GC-content of the viral (bacteriophage) water samples.
Each data point represents the mean GC-content of all pooled sequences within the
specific environmental sample.
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A graphic (Figure 5.13) was created in order to visualize the relationship between
the mean GC-content of the prokaryotic "water" samples and the mean GC-content
of the paired viral "water" samples. Figure 5.14 shows the difference in GC-content
between paired prokaryote–viral datasets. The results of the Mann–Whitney test was
used to assess the difference in GC-content between the viral and prokaryotic samples
(Table 5.10). The numbers show that in general, there is a significant difference in
GC-content between the two entities. They not only came from different distributions,
but the results also indicate that prokaryotes tended to be more GC-rich than the
bacteriophages. It is also noteworthy that statistical significance is generally more
prevalent in higher GC-content environments.
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Figure 5.13: The mean GC-content of the prokaryotic sample combined with the
mean GC-content of the paired viral sample which were obtained from the "water"
environments. The legend is colored by microbial classification, and shaped by the
environmental origin of the sample. Specifics related to the sample can be seen as
labels on the x-axis labels.
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Figure 5.14: Difference in GC-content between prokaryote and viral paired datasets.
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Table 5.10: Mann–Whitney–Wilcoxon values for the "water" datasets. Each
prokaryotic dataset is paired to a viral dataset collected at the same location and
time. *This calculation is based on the mean GC of each prokaryotic sample and
the mean GC of each viral sample.
Environment Condition p-values
Mean GC ("water" samples)* – 0.00173
Coral ConPor 1
Coral DOCPor 4.76e-28
Coral Nutrient 1
Coral pH 1
Coral T0 1.75e-214
Coral Temp 1
Fish Slime Healthy 0
Fish Slime Morbid 1
Microbialites HBC Bahamas 0
Microbialites PAS Strom 0
Microbialites RM Strom 1
Water PondFresh PrePondKentST05040 9.57e-263
Water PondFresh TilPondKentST050406 1
Water PondFresh TilPondKentST0806 5.56e-13
Water PondFresh TilPondKentST1105 1
Water PondSaline Low Salinity 0
Water PondSaline Low Salinity 1
Water PondSaline Med Salinity 2.04e-123
Water PondSaline Med Salinity 0
Water PondSaline Med Salinity 0
Water PondSaline Med Salinity 0
Water PondSaline High Salinity 0
Water Marine Christmas Islands 0
Water Marine Fann Islands 0
Water Marine King Islands 0
Water Marine Palm Islands 0
Water Marine Salton Sea 0
To expand upon the analysis, the Spearman correlation coefficient was calculated
for the mean GC-content of each prokaryotic dataset to the mean GC-content of the
paired viral dataset. The analysis also included the Spearman coefficient calculation
for each phylum to the mean GC-content of the paired viral dataset. Considering
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both types of analyses, the only significant correlations appeared for Actinobacteria
and Proteobacteria (Table 5.11).
Table 5.11: The Spearman correlation coefficient with p-value in parenthesis to
assess the relationship between the mean GC-content of each phylum to the mean
GC-content of the viral samples. The phylum values (mean GC-content) are paired
to the mean GC-content to the viral dataset collected at the same location and time.
Spearman Correlation Coefficient
A. (All) Prokaryotic vs. Viral -0.219 (0.262)
B. Phylum Spearman Correlation Coefficient
Actinobacteria 0.474 (0.011)
Bacteroidetes 0.188 (0.338)
Chlamydiae 0.005 (0.981)
Crenarchaeota -0.067 (0.737)
Deinococcus-Thermus 0.276 (0.155)
Euryarchaeota 0.355 (0.064)
Firmicutes 0.212 (0.261)
Proteobacteria 0.546 (0.003)
Spirochaetes 0.055 (0.78)
Tenericutes -0.219 (0.262)
5.5 Discussion
The trend of significant pair-wise phyla correlations (as discussed in Chapter 4),
is present in the samples from the human gut, from the Merlot vineyard soil samples,
and also from the "water" samples. The Spearman correlation results continue to
demonstrate the influence of both phylogeny and environment on prokaryotic GC-
content.
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5.5.1 Human Gut Environment
There were two metadata factors that were recorded for the human gut datasets
and one additional factor that could be inferred. Although the temperature of each
sample donor was not available, it should be a safe assumption that the level of
variation seen in mean GC-content of the samples (Figure 4.17) was not the result
of variation in bodily temperature. The mean GC-content of the human gut envi-
ronmental samples were negatively correlated to the age of the sample donor. This
was true when the samples were collectively pooled and when they were separated
by country. When the samples were separated by country, they were assigned a nu-
merical value. When the Spearman correlation coefficients were calculated using the
numerical value assigned to each country and the mean GC-content of the sample,
the correlations were significant. However, considering the geographic locations of
the sample donors, the correlations could be the result of diet, or a culmination of
several factors not included or considered in the analysis.
5.5.2 Merlot Vineyard Soil Environment
As discussed in the previous chapter and publication, the finding that each phylum
was characterized by different mean GC-contents still holds for the Merlot vineyard
soil samples [105]. It is interesting that although the GC-content sample distribution
varied far less (between∼57.5% to∼61%) than those revealed in environmental means
(Figure 4.6) and the human gut samples (Figure 4.17), the pair-wise correlations
between the phyla’s mean GC echoed the trends reported previously. This reaffirms
the idea that the environment exerts some sort of pressure which acts upon all phyla
to influence the GC-content – either in radically different environmental categories,
or within a single environment (e.g, human gut and Merlot vineyard soil). However,
it is not clear why there were no significant correlations between Tenericutes and the
111
remaining phyla. As was discussed in the last chapter, the results demonstrate that
while phylogeny is associated with a specific prokaryotic nucleotide composition, the
environment strongly influences that composition.
By contrast, of the environmental factors recorded for the Merlot dataset, there
were no significant correlations to the mean GC-content and the factors or to the mean
GC-content of each phyla save one. Between Tenericutes and temperature, the Spear-
man coefficient was significantly (and negatively) correlated. This however, does not
rule out the factors as being a contributor to influencing GC-content. The vineyard
soil conditions are heavily controlled, and it is possible that there was not sufficient
variation in the values to cause a significant change in nucleotide composition.
The results of employing CRISPRs as a means to investigate the potential of bac-
teriophages acting as instigators of (GC-content) change remain inconclusive. While
CRISPRs were found within the samples, they a) did not present a sufficient number
of spacers to determine whether the GC-content of the phages changed over time,
and b) the CRISPRs did not appear with a frequency that would allow generaliza-
tion to the remaining sequences in the sample (e.g., statistical power). Despite these
drawbacks, it is interesting to note that the GC-content of the majority of spacers
was higher than the mean GC-content of the sample. Although care must be taken in
ascribing biological meaning to this (as bacteriophages selectively infect prokaryotic
species), the GC-content of the spacers seems to reflect the high GC-content levels
found within the soil samples.
5.5.3 "Water" Environment
There was an insufficient number of observations (and variations within those
observations) to show that the GC-content could be correlated to the temperature or
pH of the environment. However, the mean GC-content was significantly correlated to
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salinity. There has been precedence for microbiome diversity being linked according
to salinity as well as GC-content [50, 75, 122].
Correlations between the mean GC-content of the paired samples (prokaryote -
bacteriophage) were not statistically significant. When the analysis was expanded to
compare the relationship between the mean GC-content of each phylum to the mean
GC-content of the paired viral dataset, there were statistically significant correlations
for Actinobacteria and Proteobacteria. The analysis showed that in the overwhelm-
ing majority of cases (18 out of the 27 cases), the GC-content of prokaryotes was
significantly higher than the GC-content of bacteriophages. However, care must be
accorded to any results as not all viruses will infect all prokaryotic cells. This logic
must also extend to the correlations in mean GC-content between the viral samples
and each of the 10 phyla in the prokaryotic paired samples. Similarly, the analysis
indicated that the GC-content of most prokaryotic samples was significantly higher
than their paired viral samples. Lastly, the GC-content distribution was distinct from
their paired viral datasets.
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6. Contributions of this Work
6.1 Broader Impacts
6.1.1 Complex Regional Pain Syndrome
This study was the first to report significant differences in the GI microbial com-
munity of CRPS subjects. Although the relationship between CRPS and GI bacteria
has not been fully established, expanding our view of the influence microbes have
on human health seems a logical step. Microbial communities have the potential to
be used as a biomarkers and could help identify disease subgroups, measure disease
state, elucidate disease mechanisms, and yield potential treatments. To date, I have
been contacted by several doctors with an interest in performing fecal transplants as
a means to alleviate the symptoms associated with CRPS.
6.1.2 GC-Content
To look at prokaryotic DNA and recognize that there is some selective force that
is overriding AT-mutation bias is to understand how the organisms evolve. In this
regard, GC-content is used as a biomarker, and like all biomarkers, they exist not
for the organism, but for researchers to study the characteristics and behavior of
the organism. To state it succinctly, GC-content is a biomarker used to study a
prokaryotic organism though the lens of adaptation.
The work outlined in previous chapters strongly indicate that prokaryotic GC-
content can be influenced by their phylogeny and environment. To understand what
factors influence GC-content is beneficial in that it helps researchers understand how
evolution can be guided.
In Figure 4.16, the GC-content of the 3rd codon position of 4-fold redundant amino
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acids can be seen. In perhaps the most striking example, in the GC-rich contaminated
soil environment, the number of guanine or cytosine nucleotides are more abundant
than the adenine or thymine nucleotides. NCBI contains thousands of prokaryotic
genomes that are used for referential purposes by the scientific community. However,
in the 3rd codon position of 4-fold redundant amino acids, the prominent selection
of guanine and cytosine in high GC-content environments and adenine and thymine
in low GC-content environments brings into question the reliability of the referen-
tial genome, and what presented environmental conditions sculpted the referential
genome.
6.2 Recommendations for Future Work
6.2.1 Complex Regional Pain Syndrome
Although challenging, often because of the medications prescribed to CRPS suf-
ferers which alter their GI microbial community – one of the first items to address is
the size of the studied population. Increasing the number of subjects can validate the
results of this work. Additionally, because there is a great deal of diversity in symp-
tom expression, it is also possible to uncover microbiome trends based on a subject’s
syndrome indications. Further, shotgun sequenced studies should be incorporated
to determine if the metabolic pathways differ not only between healthy controls and
those with CRPS, but also within the CRPS disease subsets.
Lastly, a recent study by Kriegala et. al., indicated a relationship between CRPS
and certain human leukocyte antigen (HLA) haplotypes [128]. In future studies I
would like to combine the finding of the bias in microbial populations in the GI tract
of CRPS patients with this finding regarding their biased HLA usage. It would be
interesting to determine to what extent the HLA bias in CRPS patients predisposes
them to present specific antigens and epitopes of the GI microbiota, and if this can
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be related to changes in the microbiota and in the immune reaction to those changes.
This is an imminently computable task as good computational models exist that can
derive the HLA specific epitopes of any bacteria or virus given its sequence structure
[51]. I could therefore – through a set of shotgun sequencing experiments, compare
both the biota population changes and how they appear to the immune system via
their epitopes. I would then relate this to the HLA type of the patients and their
CRPS outcome as well as their general immune function (as determined by cytokine
levels and neutrophil counts). In this fashion I could combine the microbial outlook
with its immune counterpart and show how these two dynamic and interconnected
systems influence the neural system and generate CRPS.
6.2.2 GC-Content
Although it is a relatively simple task to look at measured values (metadata)
and compute correlations for potential relationships to prokaryotic nucleotide com-
position, an issue with utilizing publicly available data is that one is not in control
of what factors (e.g., temperature) were measured at sampling time. Researchers
should measure as many environmental factors as possible when collecting metage-
nomic samples and make them publicly available. This could greatly assist narrowing
down which factor(s) have a greater impact (via correlations) on GC-content.
After the work done to link bacteriophages to prokaryotic GC-content, it is still
not possible to state definetively whether bacteriophages influence GC-content. When
viewed from the CRISPR perspective, with increased sequence lengths, CRISPRs can
be more readily identified. Not only does the probability of finding CRISPRs through-
out the metagenomic prokaryotic datasets increase, one could inspect the the spacers
to determine whether there is a shift in the GC-content of the bacteriophage, and
correlate it to the GC-content of the host. Along with the previous point, compu-
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tational tools need to be developed to aid in the classification of viral metagenomic
reads. All of these could better facilitate researchers identifying viruses from shotgun
metagenomic samples. In late 2014, Muhire et. al., published an article on their
Sequence Demarcation Tool [86]. Future works should employ or develop a similar
tool to classify viral metagenomic samples. Furthermore, benchmarking and incor-
porating multiple CRISPR identification programs (e.g, PILER-CR [38]), may allow
for increased CRISPR identification and assessment of a spacer’s GC-content from a
historical vantage point. Additionally, virus outnumber prokaryotes by an estimated
10:1. As phages – when possible, selectively infect prokaryotic cells, researchers should
continue to study viral genomes and publish a database of which viruses infect which
prokaryotic strains. This information could be used to determine if the GC-content
of the phage is correlated to the GC-content of the species/strains of prokaryote.
Based on the work performed on the 3rd codon position of 4-fold redundant amino
acids, it may be worthwile to select specific genes – particularily those that are highly
conserved to investigate whether there is preferential selection for guanine and cyto-
sine in GC-rich environments, and preferential selection for adenine and thymine in
AT-rich environments. Should there be preferential nucleotide selection, there could
be ramifications on primer design. Continued advancements in next generation se-
quencing will produce longer reads. Increased read-length will increase the confidence
affiliated with the classification of metagenomic sequences (and CRISPR identifica-
tion). This will also allow researchers to classify sequences – especially non-16S rRNA
sequences (e.g., shotgun sequences) to a much finer taxonomic class (e.g., strains).
Lastly, there is still the question as to whether a microbe with a specific GC-
level must evolve quickly to an environment with different GC-levels or whether the
microbe cannot survive in a drastically distinct GC environment. Although it is likely
that survival is not based on having a specific GC-level, answering this question would
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be aided by the simultaneous addition of wet lab research. In this setting, a microbe
could be introduced into a community, and researchers could observe how and/or if
the nucleotide composition alters and the time it takes for these alterations to occur.
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